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Abstract 
Understanding the subcellular localization of a protein or protein clusters is helpful to conceive 
the function of the proteins or the mechanism of the pathway involving these proteins. Bacteria, 
although small and single-celled, have been shown to have delicate subcellular locations for most 
of its components. The modified two-component chemotaxis system employed by bacteria has a 
core where the receptors form ternary complexes with CheA histidine kinases and CheW adaptor 
proteins. These complexes are arranged in semi-ordered arrays clustered predominantly at the 
cell poles. The prevailing models assume that these arrays are static and reorganize only locally 
in response to attractant binding. Recent studies have shown, however, that these structures are 
in fact much more fluid. Previous study on localization of the chemotaxis proteins is mostly in 
Escherichia coli, which is relatively simple in terms of chemotaxis proteins it has and the 
mechanism it utilizes. In contrast, the gram-positive soil bacterium Bacillus subtilis has at least 
one copy of all the chemotaxis proteins found up to now and represents a general model for 
chemotaxis in bacteria.  
In this work, we investigated the dynamic localization of the chemotaxis signaling arrays in B. 
subtilis using immunofluorescence. We found that the receptors were localized in clusters at the 
poles in most cells. However, when the cells were exposed to attractant, the number exhibiting 
polar clusters was reduced roughly two-fold whereas the number exhibiting lateral clusters 
distinct from the poles increased significantly. The redistribution of the receptors was reversible, 
as polar localization was reestablished in adapted cells. We also investigated the dynamic 
localization of CheV, a hybrid protein consisting of an N-terminal CheW-like adaptor domain 
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and a C-terminal response regulator domain that is known to phosphorylated by CheA. 
Interestingly, we found that CheV was localized predominantly at lateral clusters in unstimulated 
cells. However, upon exposure to attractant, CheV transiently relocalized to the cell poles. 
Moreover, CheV relocalization was phosphorylation dependent. Collectively, these results 
demonstrate that the chemotaxis signaling arrays in B. subtilis are dynamic structures and that 
feedback loops involving phosphorylation may regulate the positioning of individual proteins. 
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Chapter 1: Introduction 
1.1 Bacteria motility and chemotaxis 
Bacteria, in spite of their tiny size, typically 0.5-5 micrometers, and relatively simple 
structure consisting of a single cell, are able to survive and even thrive in harsh and 
constantly-changing environments. Motility is one of the most important strategies they 
have evolved against a variety of threats. Bacteria, when swimming, can move really as 
fast as 100 body lengths per second, which is the speed of fish on a relative scale. This 
allows them to flee hostile enviroments and swim towards nutrient sources. 
Bacteria attain motility using a diversity of mechanisms. They may employ flagella for 
swimming or pili for gliding and twitching [1]. The best studied is through the rotation of 
flagella, which function much like the propellers on a ship and its rotation is driven by a 
reversible motor at the base. Bacterial flagella are the best-known motility apparatus in 
all organisms [1,2,3,4]. It is composed of about 20 proteins and requires another 
approximately 30 proteins for its regulation and assembly. The number and arrangement 
of flagella on the cell surface can be diverse. Monotrichous bacteria, e.g. Vibrio cholerae, 
have a single flagellum. Amphitrichous bacteria have a single flagellum on each of two 
opposite ends with only one flagellum operating at a time and allow the bacteria to 
reverse course rapidly by switching which flagellum is active. Lophotrichous bacteria 
have multiple flagella located at the same spot on the bacteria's surfaces, usually a cell 
pole. They act in concert to drive the bacteria in a single direction [1,4]. Many bacteria 
are peritrichous with flagella distributed over the entire surface of the cell, like the gastro-
intestinal gram-negative bacterium Escherichia coli and the soil-based gram-positive 
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bacterium Bacillus subtilis. They have two modes of movement: forward movement 
(smooth swimming) and tumbling depending on how the flagella rotate. Smooth 
swimming is caused by the counter-clockwise (CCW) rotation of the flagella and 
tumbling is caused by clockwise (CW) rotation (Figure 1.1). When smooth swimming 
occurs, bacteria run forward in one direction; tumbling enables them to reorient and 
makes their movement by a three-dimensional random walk [5,6]. 
 
Figure 1.1: Two modes of movement of peritrichous bacteria. 
CW rotation of the flagella causes bacteria to tumble and CCW rotation allows them to 
swim smoothly. 
Motility by itself would be of debatable advantage considering the energy and resources 
it takes to synthesize and power the delicate huge motility apparatus. However, motility 
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is always directed towards a more favorable environment since bacteria can sense their 
environment, steer the rotation of their flagella and run towards more friendly conditions. 
This process is called chemotaxis [7,8]. Due to their tiny size, bacteria cannot spatially 
sense the chemical gradients. Rather, they accomplish it temporally by alternating 
between smooth swimming and tumbling [9]. In isotropic enviroments, the ratio of time 
in smooth swimming and tumbling is about 50/50. When tumbling, a cell can randomly 
reorient itself in three dimensions aiming for next smooth swimming. When it detects an 
increasing attractant gradient, longer events of smooth swimming occur. The resulting 
biased random walk towards more favorable enviroments is achieved through the control 
of the flagellar rotation by the bacteria chemotaxis pathway (Figure 1.2). 
 
Figure 1.2: Random and biased walk. 
1.2 Two-component signal transduction 
Chemotaxis signals are sensed and transduced by a two-component system [10]. The 
two-component systems are widespread among living organisms ranging from bacteria, 
archaea and some single-celled eukaryotes to higher plants [11,12]. They regulate diverse 
processes including nutrient acquisition, energy metabolism, virulence, adaptation to 
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physical or chemical aspects of the environment, and complex developmental pathway. 
In fact, they appear to be one of the predominant control systems in bacteria and archaea. 
The E. coli genome contains 30 two-component systems and the B. subtilis genome 
contains 70 two-component systems [13,14].  
Namely, the two-component systems require two components from the stimulus to the 
target response regulation. The first component is typically a membrane-bound protein 
called histidine kinase (HK) with a sensor domain and a kinase domain. The second 
component is called the response regulator (RR). Once stimulated, the sense domain of 
the HK can sense the environmental stimulus like attractant and cause its kinase domain 
to auto-phosphorylate on a conserved histidine residue using ATP as substrate [15,16,17].  
Then it transfers the phosphoryl group to a conserved aspartate residue on the RR. The 
resulting phosphorylated RR is generally the active form and generates the desired 
response which is usually gene expression [18]. Consequent de-phosphorylation of the 
RR can reset the system and enable it to accept next stimulus (Figure 1.3). 
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Figure 1.3: Two-component signaling transduction system. 
1.3 The chemotaxis system 
The chemotaxis signal transduction system is a modified two-component system with 
motility as the output. CheA is the histidine kinase. It is a cytoplasmic protein linked to 
chemoreceptors through a coupler protein CheW [19,20,21]. These chemoreceptors, also 
called methyl-accepting chemotaxis proteins (MCP‟s), are transmembrane proteins which 
can sense the periplasmic cues and pass this information to CheA either enhancing or 
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inhibiting its autophosphorylation rate [22,23,24,25]. CheY is the response regulator in 
this system and can accept the phosphoryl group from CheA-P [26,27]. The resulting 
CheY-P will bind to FliM in the flagellar switch and bring about CW rotation of the 
flagella which causes tumbling [28,29,30,31]. The MCP-CheW-CheA-CheY-FliM forms 
the basis of the chemotactic signaling pathway (Figure 1.4). 
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Figure 1.4: Chemotaxis system. 
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In addition, this system has modification enzymes which vary from species to species to 
bring the system back to prestimulus status and get it ready for higher concentration of 
ligand. The E. coli system has three other proteins CheR, CheB, and CheZ. CheR is a 
methyltrasferase which transfers methyl groups from S-adenosyl methionine (SAM) to 
certain conserved residues on MCP [32,33,34]. CheB is a second response regulator 
which accepts phosphoryl groups from CheY-P and CheB-P serves as a methylesterase 
which hydrolyzes the methyl-glutamates and release the methyl groups as methanol 
[35,36]. The CheR/CheB methylation system is found in most bacterial chemotaxis 
pathway and plays important roles in adaptation by controlling the methylation status of 
MCP. CheZ is a CheY-P phosphatase found only in the proteobacteria [26]. It binds to 
CheY-P and removes the phosphoryl group from it. 
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Figure 1.5: The E. coli chemotaxis model. 
1.4 The Bacillus subtilis chemotaxis 
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Most understand of bacterial chemotaxis on a molecular level is based on studies in the E. 
coli system (Figure 1.5). However, this paradigm represents a relatively simple and 
optimized model. Although all based on a two-component system and sharing many 
homologous components, chemotaxis is quite diverse in the sense that various 
components and different mechanisms are utilized by different species. Hence research 
on chemotaxis has expanded to organisms with “novel” components and more complex 
mechanisms to get a more comprehensive understanding of this fundamental pathway. 
The B. subtilis chemotaxis pathway provides an ideal model to investigate its diversity 
and commonality because of its complexity and inclusion of most known chemotaxis 
genes. In addition, it is similar to the one used in many archaea, which suggests that the B. 
subtilis mechanism is ancient and close to the progenitor mechanism existing before the 
divergence of bacteria and archaea. Therefore, the studying of B. subtilis chemotaxis can 
aid in the understanding of the evolution and divergence of this pathway. 
B. subtilis has many of the same chemotaxis proteins as E. coli. The CheA, CheY, CheW, 
CheB, and CheR are homologous in both organisms [6]. B. subtilis also has MCP‟s 
similar to those in E. coli but with a bigger number: 10 are found in B. subtilis and 5 in E. 
coli. However, several differences show B. subtilis as a more general model of 
chemotaxis (Figure 1.6). 
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Figure 1.6: The B. subtilis chemotaxis model. 
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The first divergence is in the response to an attractant and the flagellar rotation. In E. coli, 
the default rotation is CCW and CheY-P binding to the switch causes CW rotation [37]. 
Attractant binding to the receptor causes an inhibition of CheA activity and a decrease of 
CheY-P levels, thus resulting in a default CCW rotation of flagella for a smooth 
swimming. Repellant binding or the removal of attractant causes an increase in CheA 
activity and CheY-P levels which leads to a tumbling response. The B. subtilis system has 
the same response to attractant and repellant but utilizes a different molecular mechanism 
[38]. Here the default rotation is CW. Receptors bounded to attractants activate CheA. 
Then CheY-P levels are increased and cause the flagella to switch to a CCW rotation 
which means smooth swimming. 
The B. subtilis system lacks a CheZ homolog but contains the flagellar switch protein 
FliY which has a CheC-like domain and a C-terminus domain homologous to E. coli FliN 
[6]. FliY can bind to CheY-P and is shown to be a CheY-P phosphatase. A fliY mutant 
unable to bind CheY-P is generally smooth swimming. Therefore it was thought to be the 
main phosphatase of CheY-P in the chemotaxis pathway of B. subtilis and related species 
[6,39]. 
B. subtilis has three proteins CheV, CheC, and CheD, not found in E. coli but found in 
most other chemotactic bacteria studied up to now [6]. It appears that B. subtilis represent 
the paradigm model for bacterial chemotaxis, as it has at least one copy of all the 
chemotaxis proteins found throughout the bacteria and archaea kingdoms.  
Due to the presence of these “novel” chemotaxis proteins, B. subtilis has two additional 
adaptation systems other than the methylation dependent one mediated by CheB/CheR 
13 
 
which is similar to that in E. coli. The second one is based on the CheC-CheD-CheY-P 
feedback loop. CheC is found to be capable of removing the phosphoryl group from 
CheY-P. However, its major function is not as a phosphatase but adaptation [40]. This is 
realized by its ability to bind to both CheY-P and CheD. CheD is a deamidase which 
converts certain glutamine to glutamate ready for methylation, and is shown to be 
essential for receptor methylation and CheA activation [38,41,42,43]. Binding of CheD to 
CheC enhances its phosphatase activity. As far as we understand now, when elevated 
levels of CheY-P is present, the formed CheC-CheY-P complex has higher affinity for 
CheD compared to CheC alone, thus drawing CheD away from receptors and leading to a 
decrease in the level of active CheA and a slight decrease in the CheY-P levels. In short, 
CheC, CheD, and CheY-P form a negative feedback loop that leads to kinase inactivation 
and adaptation [44]. Another adaptation system involves the protein CheV, which is a 
third response regulator with an N-terminus CheW-like domain and a C-terminus CheY-
like domain. Mutation or deletion of the response regulator domain defect their ability to 
adapt, though cells can still perform chemotaxis. Apparently CheV is involved in 
adaptation dependent on its ability to be phosphorylated, but how this happens is not 
known.  
The three adaptation systems coordinate with each other in a way still not understood to 
date and allow cells to adapt to a wide range of attractants. While deletion of any one is 
not detrimental to the overall chemotactic ability of the cell, deletion of any two the three 
has a severe effect on chemotaxis [44]. 
1.5 Localization of chemotaxis proteins 
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Spatial organization of signaling protein components within bacteria cells, despite their 
smaller sizes, is of great importance to cell function but complex and poorly understood. 
The bacterial chemotaxis system has been shown to have complex subcellular 
localizations. The mechanisms underlying the spatial arrangement of its components have 
mostly studied in E. coli with the simplest chemotaxis model.  
 
Figure 1.7: Localization of the receptor clusters in E. coli. 
A. Localization of the receptor clusters monitored by the YFP-CheR fusion; B. 
Localization of the receptor clusters monitored by the Tar-mEos. 
The chemotaxis complexes in E. coli are shown to be located primarily at one or both of 
cell poles and also form weak clusters laterally at periodical positions which mark every 
1/8 of a cell length serving as fusion division sites [45,46,47,48,49] (Figure 1.7). At the 
center of the clusters are the chemoreceptors, which can aggregate and assemble into 
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clusters by receptor-receptor interaction [45] through a highly conserved domain (HCD) 
in the cytoplasmic signaling tip, possibly responsible for the formation of trimers of 
receptor dimmers [50,51]. The binding of CheW and CheA to receptors independently 
can further enhance and stabilize the clusters [45,46,52]. Co-localization of CheA to 
receptors can be enhanced by the presence of CheW [48]. 
Other chemotaxis proteins also localize to these clusters. CheY and CheZ co-localize 
with MCPs independently, but both through interactions with the MCP-CheW-CheA 
complex. CheY interacts with CheA-P for phosphorylation. CheZ is shown to interact 
with the short form of the histidine kinase, CheAs, and localize to the chemoreceptor 
clusters via CheAs [48,53,54,55,56]. CheR is recruited to the chemoreceptor clusters 
through the binding of its β-subdomain to the C-terminal pentapeptide sequence 
(NWETF) of high-abundance MCPs (Tsr and Tar) [57]. CheB also binds to the NWETF 
sequence, but the affinity is really low (Kd=160 μM) [58,59].; while its affinity to CheA 
(Kd=3.2 μM) (Li et al., 1995) is much higher and comparable to the affinity of CheR‟s 
binding to the NWETF sequence (Kd=2 μM) (Wu et al., 1996), suggesting CheA a more 
likely target for CheB. Localization study confirms that the P2 domain of CheA is 
essential for CheB to co-localize to the chemoreceptor clusters [60]. 
The formation of large clusters of chemotaxis complexes is thought to play a critical role 
in cooperative integration and amplification of signals, which might account for the high 
response sensitivity of this system [45]. There is evidence that attractant binding and 
MCP modification can affect the cluster stability, especially low-abundance 
chemoreceptors [61,62,63,64]. Also attractant binding can alter the arrangement of 
chemoreceptors in polar clusters by reducing the number of higher receptor oligomers 
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[65]. On treatment of the low-abundance chemoreceptor with synthetic multivalent ligand, 
cells are 100-fold more sensitive to the attractant serine. All these suggest that signal 
processing by the chemotaxis system is relevant to the dynamic clustering of the complex. 
The gram positive bacteria B. subtilis has a more complex chemotaxis system than E. coli. 
Most of its components have been identified and characterized. It has ten receptors and 
more Che-proteins: CheV, CheC, and CheD. But not much is known about its spatial 
organization in the cell. Immunofluorescence study using anti-McpB antibody has shown 
that the complex clusters at cell poles [66]. But the receptor complex tends to diffuse if 
signal amplification needs to be inhibited, like treated with a high concentration of 
attractant [67]. The localization of the receptors in another gram positive bacterium 
Bacillus pseudofirmus is also studied using anti-McpB antibody. It is shown that the 
polar location of the MCP complex is NavBP dependent which is essential of normal 
chemotaxis response in alkaline conditions at suboptimally low Na+ concentrations. The 
polar localization pattern of MCPs is also decreased in ΔCheAW mutant [68]. 
1.6 Scope of this work 
As localization of signaling proteins can reveal a lot about their function and the 
interaction between them, like the study in E. coli, this work is aimed to investigate the 
localization of some chemotaxis proteins in B. subtilis, especially those not present in E. 
coli, the localization of which have not been studied in any organism yet. Through either 
immunofluorescence staining or fluorescent protein fusion, we aim to locate their 
positions in the cell, especially relative to the receptor clusters, and more importantly 
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investigate the change of their spatial arrangement in response to stimuli. These 
information would be of great help uncover their role in adaptation. 
The main focus of this work is to investigate the localization of the protein CheV and the 
change of its positions relative to the receptor McpB upon stimulus using 
immunofluorescence staining. CheV is found to form a negative feedback loop with 
CheA and it is spatially regulated. It is also shown that the function and localization of 
CheV is affected by its ability to be phosphorylated.  
Also described in this thesis are three other projects I have worked on during my Ph.D. 
program. One regards how the configuration of a promoter can affect its behavior. This 
leads to another work about constructing synthetic overlapping divergent promoters. Last, 
I have built a modular positive feedback gene circuit which can serve as chemical sensors 
when coupled with promoters induced by the chemical. 
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Chapter 2: Materials and Methods 
2.1 Growth media 
Luria-Bertani (LB) media is used for proliferation of bacterial cells. Premixed LB powder 
and agar are purchased from BD Difco
TM
. To make 1L liquid LB media, dissolve 25 g 
LB powder, containing 10 g tryptone, 5 g yeast extract, and 10 g NaCl, in deionized 
water ((Milli-Q water) and adjust the final volume to 1L. For solid LB agar plate, add 15 
g agar to 1 L liquid media. Media are sterilized by autoclaving at 121°C/15 psi for 20 
min
1
.Cells are all grown at 37°C unless otherwise specified. Antibiotics are used at the 
following concentration if needed. For resistance genes on plasmids in E. coli, ampicillin 
is used at a concentration of 100 μg/mL, chloramphenicol at 25 μg/mL, and kanamycin at 
40 μg/mL. For resistance genes on the chromosome of E. coli, chloramphenicol is used at 
a concentration of 6 μg/mL and kanamycin at 10 μg/mL. For B. subtilis, chloramphenicol 
is used at a concentration of 5 μg/mL, erythromycin at 1 μg/mL, kanamycin at 10 μg/mL, 
and spectinomycin at 100 μg/mL. 
Tryptone broth (TB) is used to make minimal media CAMM. It contains 1% (w/v) 
tryptone (from BD Difco
TM
) and 0.5% (w/v) NaCl
2
. Sterilize by autoclaving. 
SOB is used to subculture for preparing competent cells. For every 1 L SOB, dissolve in 
deionized water 20 g tryptone, 5 g yeast extract (from BD Difco
TM
), 0.5 g NaCl, and 10 
                                                 
1
 Otherwise a solution is sterilized by passing it through a 0.22 μm filter. 
2
 Salts are purchased from Sigma or Fisher unless otherwise specified. 
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mL of 250 mM KCl, and then adjust pH to 7.0 with 5M NaOH. Sterilize by autoclaving. 
Before use, add 5 mL of sterile 2M MgCl2. 
SOC is used to recover cells after heat shock or electroporation. For every 1 L SOC, 
dissolve in deionized water 20 g tryptone, 5 g yeast extract (from BD Difco
TM
), 0.5 g 
NaCl, and 10 mL of 250 mM KCl, and then adjust pH to 7.0 with 5M NaOH. Sterilize by 
autoclaving. Before use, add 5 mL of sterile 2M MgCl2 and 20 mL of sterile 1 M glucose. 
The Capillary Assay Minimal Media plus TB (CAMM+) is used to culture B. subtilis 
cells for assay. It contains 50 mM K3PO4, pH 7.0, 1.2 mM MgCl2, 0.14 mM CaCl2, 1 mM 
(NH4)2SO4, 0.01 mM MnCl2. Sterilize by autoclaving. Before use, add 0.2% (v/v) TB, 20 
mM sorbitol, and 50 μg/mL of histidine, methionine, and tryptophan.  
Minimal media GM1 and GM2 are used for spizizen transformation of B. subtilis cells. 
To make 10 mL of GM1, mix the following sterile solutions: 8.4 mL of water, 1mL of 
10X spizizen salts, 250 l of 20% glucose, 40 l of 5% Casamino Acid (CAA), 100 l of 
5 mg/mL HMT (Histidine, Methionine, Tryptophan), and 200 l of 1 M MgCl2. To make 
10 mL of GM2,  mix the following sterile solutions: 8.7 mL of water, 1mL of 10X 
spizizen salts, 250 l of 20% glucose, 20 l of 5% Casamino Acid (CAA), and100 l of 
5 mg/mL HMT. 
Swarm plates are used to test the ability of B. subtilis cells to move in soft agar. It may be 
made of tryptone broth or minimal media. Tryptone swarm plate is made from tryptone 
broth plus 0.3% agar. Sterilize by autoclaving. Minimal media swarm plate is made by 
mixing sterile solutions with 0.3% agar. For example, to make 50 mL of asparagine (Asn) 
minimal media swarm plates, add to 45 mL of sterile water 1 mL of 10X spizizen salts, 
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100 l of 5 mg/mL HMT, 50 l of 0.7 M sorbitol, and 150 l of 0.1 M Asn. Heat the 
mixture about 30-60 sec by microwave oven and then add 5 mL of melt 3% agar. Mix 
and pour plates with 10 mL for each. Attractants are used at different concentrations: Asn 
at 0.3 mM and Pro (proline) at 0.2 mM. 
Starch plates are regular LB plates plus 1% starch. They appear opaque and are used to 
test if integration occurs at the amyE site on B. subtilis chromosome.  A colony with no 
integration at the amyE site is capable of degrading starch and generates a transparent 
circle around it. Integration disrupts the amyE gene and deprives cells‟ ability to degrade 
starch. Thus media around the colony is still opaque. 
M9 minimal media with glucose are used to assay cells expressing fluorescent proteins. 1 
L of M9 minimal media contain 200 mL of 5X M9 salts, 2 mL of 1 M MgSO4, 0.1 mL of 
1M CaCl2, 20 mL of  20% glucose, 10 mL of 10% CAA, and 0.1 mL of 10 mg/mL 
thiamine. Salts and water are sterilized by autoclaving. Other solutions are sterilized by 
filtering. 
2.2 Buffers 
10X spizizen salts = 2% (w/v) (NH4)2SO4, 14% (w/v) K2HPO4,6% (w/v) KH2PO4, 1% 
sodium citrate,0.2% (w/v) MgSO4. Sterilize by autoclaving. 
PBS (Phosphate buffered saline) = 0.01 M phosphate buffered saline, 0.138 M NaCl, and 
2.7 mM KCl, pH 7.4. A premixed PBS powder distributed in packets is purchased from 
Sigma with one pouch dissolved in 1 L deionized water. 
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TBS (Tris buffered saline) = 100mM Tris·Cl, pH 7.5, 150 mM NaCl. Store at 4 °C up to 
several months. 
Blocking buffer = 2% BSA in PBS 
TAE (Tris/acetate/EDTA) electrophoresis buffer = 40 mM Tris·acetate, 2 mM 
Na2EDTA· 2H2O, pH 8.5. 
TE (Tris/EDTA) buffer = 10 mM Tris·Cl, pH 7.4; 1 mM EDTA, pH 8.0. 
Inoue transformation buffer = 55 mM MnCl2, 15 mM CaCl2, 250 mM KCl, and 10 mM 
PIPES (0.5M, pH 6.7). Store at -20 °C. 
2.3 Protocols 
2.3.1 Preparation of “ultra-competent” E. coli cells 
1. Streak the host cells on a LB agar plate and incubate at 37 °C for 16-20 hr. 
2. Pick a colony, start a 1 mL culture in LB and shake vigorously for 6-8 hr at 37°C. 
3. Subculture in 50mL SOB (1:50 dilution) in a 0.25 L flask and shake overnight at 
room temperature. 
4. When the OD600 of the subculture reaches 0.55, transfer the flask into ice for 10 min. 
5. Harvest the cells in a 50 mL conical tube by centrifugation at 4000 rpm (Eppendorf 
centrifuge 5810R) for 10 min at 4 °C. Discard the supernatant and drain the 
remaining media by invert the open tube onto paper towel for 2 min. 
6. Resuspend the cells gently by flipping the tube back and forth in 16 mL ice-cold 
Inoue transformation buffer. 
7. Spin down the cells again at 4000 rpm for 10 min at 4 °C. Discard the supernatant. 
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8. Resuspend the cells gently in 20 mL ice-cold Inoue transformation buffer. 
9. Add 1.5 mL DMSO. Mix the suspension by swirling and store it in ice for 10 min. 
10. Quickly dispense aliquots into pre-chilled 1.5 mL tubes and immerse them in dry ice 
for a few minutes. Store the tubes of competent cells at -80 °C. 
2.3.2 Heat-shock transformation 
1. Mix DNA with 50-100 l ultra-competent cells described in section 2.3.1 in a 1.5 mL 
tube. Use 1 l DNA if it is purified plasmid and 10 l if it is ligation mixture. 
2. Put it on ice for 30 min. 
3. Transfer the tube to water bath at 42 °C for 2 min. 
4. Put it back on ice for 5 min. 
5. Add 1 mL SOC to the tube and transfer the cells to a test tube. 
6. Recover the cells by shaking for 45-60 min at 37 °C. 
7. Transfer 200 l of the cells onto a LB agar plate containing the appropriate antibiotic. 
Spread evenly on the surface of the plate until the liquid is absorbed by the agar. 
8. Incubate the plate at 37 °C overnight.  
2.3.3 Preparation of electro-competent cells 
1. Start a LB culture of the host strain in a test tube and shake it at 37 °C overnight. 
2. Subculture in 50 mL SOB with a 1:50 dilution for about 3-4 hr until the OD600 
reaches around 0.6. 
3. Harvest cell by centrifugation at 4000rpm for 10 min at 4 °C. 
4. Discard the supernatant and resuspend the cells in 25 mL 10% ice-cold glycerol by 
vortexing. 
27 
 
5. Repeat step 3 and 4 twice. 
6. Spin down the cells again for 10 min at 4 °C, and discard most of the supernatant 
leaving about 1-2 mL in the tube. 
7. Resuspend cells by pipetting. The cells are ready to use and can be stored at -80 °C. 
2.3.4 Electroporation 
1. Mix 1 l DNA with 50l electro-competent cells described in section 2.3.3 and 
transfer to a 2mm electroporation cuvette (from Genesee Scientific). Usually purified 
DNA is used for electroporation.  
2. Cells are electroporated using a BioradMcro Pulser. 
3. Add 1 mL SOC and transfer to a test tube, and then shake it for 1 hr at 37 °C to 
recover the cells. 
4. Spread 200 l of the cells onto a LB agar plate containing the appropriate antibiotic. 
5. Incubate the plate at 37 °C overnight. 
2.3.5 Extraction of genomic DNA from bacteria 
This protocol works well for both gram-positive and gram-negative bacteria. 
1. Start a 1-2 mL LB culture of the strain and shake it at 37 °C overnight. 
2. Spin down the cells for 2 min in a 1.5 mL tube at maximum speed in a 
microcentrifuge. 
3. Discard the supernatant and resuspend the pellet with 567 l TE buffer, and add 30 l 
10% SDS and 3 l 20mg/ml proteinase K. Mix by pipetting and incubate for 1 hr at 
37 °C. 
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4. Add 100 l of 5 M NaCl and mix by pipetting. Add 80 l of CTAB/NaCl solution 
(0.7M NaCl, 10% CTAB, heating to 65 °C to dissolve) and mix by shaking. Incubate 
for 10 min in a 65 °C water bath. 
5. Add an equal volume (about 0.75 mL) of chloroform/isoamyl alcohol, mix by 
flipping the tube several times. Spin 5 min at maximum speed in a microcentrifuge. 
6. Transfer the supernatant to a fresh tube. Add an equal volume of 
phenol/chloroform/isoamyl alcohol, extract thoroughly, and spin in a microcentrifuge 
for 5 min. 
7. Transfer the supernatant to a new tube. Add 0.6 volume isopropanol to precipitate the 
nucleic acids. Shake the tube back and forth. Spin down briefly in microcentrifuge.  
8. Remove the liquid by XXX. Wash the precipitate with 70% ethanol. Remove all 
liquid and let the pellet dry by leaving the tube open. 
9. Resuspend the pellet in 100 l TE buffer. Store at -20 °C. 
2.3.6 Spizizen transformation of B. subtilis cells 
1. Streak out the host strain on a LB plate and incubate overnight at 30 °C. 
2. Scrape cells off the plate and dissolve in GM1 minimal media. Dilute cells to a final 
OD600 of 0.2-0.3 in 1 mL GM1 media. 
3. Shake vigorously for 4-4.5 hr at 37 °C. 
4. Add 100 l cells to 800 l prewarmed GM2 minimal media. 
5. Shake for 1.5 hr at 37 °C. 
6. Add 1-10 l of DNA, either a miniprep, genomic DNA, or digest DNA fragments, to 
the test tube. 
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7. Incubate without shaking for 1-4 hr at 37 °C. 
8. Spin down the cells for several minutes at a speed lower than 4000 rpm. Discard most 
of the supernatant and resuspend the pellet in the remaining media. 
9. Spread all the concentrated cells on a LB plate with the appropriate antibiotic.  
10. Incubate at 37 °C overnight. 
2.3.7 Phage P1 transduction 
1. Start an overnight culture of the strain containing marker of interest. 
2. Dilute 1:100 and subculture in 2 mL LB with 5 mM CaCl2 at 37 °C for 1 hr. 
3. Add 20 l of P1 lysate grown on a wild-type strain. Grow for 2-4 hrs until lysed. 
4. Add 50 l of chloroform to kill bacterial cells. Vortex for 10-30 sec to break 
remaining bacterial cells. 
5. Spin at ~3000 rpm for 10-15 min at room temperature. 
6. Transfer supernatant to new tube. The lysate can be stored at 4 °C. 
7. Grow an overnight culture of the recipient strain. 
8. Spin down the cells and resuspend them in half of the original volume in 10 mM 
MgSO4, 5mM CaCl2. 
9. Add 50 l of the P1 lysate to 100 l of the resuspended cells with control having cells 
or phage only. 
10. Incubate at 37 °C for 30 min without shaking. 
11. Add 1 mL of LB with 0.1 M sodium citrate. 
12. Grow at 37 °C for 1 hr with gentle shaking. 
13. Concentrate cells by spinning them down and discarding most of supernatant. 
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14. Spread cells on selective plates and incubate at 37 °C overnight. 
15. Restreak colonies on LB plates with 0.1 M sodium citrate. Restreak again on selective 
plates. 
2.3.8 Pre-absorption of antibodies using acetone powder 
1. Start an overnight culture of the strain with the antibody target deleted in LB at 37 °C. 
2. Dilute 1:100 and subculture in 800 mL LB for 3-4 hr at 37 °C until OD600 reaches 
0.5-1.0. (8X100 mL with each 100 mL in a 0.5 L flask) 
3. Spin cells down at 4000 rpm in 50 mL conical tubes for 10 min at 4 °C. 
4. Discard all the supernatant. Resuspend in 3 mL 0.9% NaCl and transfer to one conical 
tube. The resulting volume is around 4 mL. 
5. Add 4 mg lysozyme, mix, and incubate for 30 min at 37 °C. 
6. Add 16 mL acetone, mix, and incubate on ice for 30 min with shaking every 5 min. 
7. Spin at 4000 rpm for 10 min at 4 °C. 
8. Discard supernatant and resuspend pellet in 20 mL acetone. 
9. Leave it on ice for 10 min. 
10. Spin again at 4000 rpm for 10 min at 4 °C. 
11. Discard supernatant. Transfer the pellet from the tube onto a piece of filter paper to 
absorb the liquid. Transfer the dry cells onto a piece of weighing paper in a mortar 
and smash it with a pestle. 
12. Transfer the completely dry fine powder to a sterile tube and store at -20 °C. 
13. Dilute the antibody 1:10 in TBS in a 1.5 mL tube. 
14. Add acetone powder to ~1% (W/V), mix, and incubate for 20-30 min at room 
temperature. 
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15. Spin at max speed (14,000 rpm) for 5 min. 
16. Transfer the supernatant to a new tube and repeat step 14-15 five times. 
17. Transfer the supernatant to a new tube and store at 4 °C. 
2.3.9 Immunofluorescence staining 
1. Start an overnight culture in CAMM+ at 37 °C. 
2. Subculture with an initial OD600 of 0.06 and grow at 37 °C until OD reaches 0.4-0.6. 
3. Fix in 2.5% paraformaldehyde for 15 min at room temperature and 30 min on ice. 
4. Transfer 200 l cells to a poly-L-lysine pretreated 12mm round coverslip (from BD 
BioCoat) placed in a 3.5cm Petri dish and leave it on bench for 5 min. 
5. Remove excess solution and wash 3X 5 min with the blocking buffer.  
6. Treat cells with 0.1 mg/mL lysozyme in the blocking buffer for 20 min. 
7. Wash 3X 10 min with the blocking buffer. 
8. Transfer the coverslip onto the parafilm in a humidifier chamber, a big Petri dish with 
half of the bottom covered with parafilm and the other half with soaked wiping paper. 
Add 150 l of the pre-absorbed primary antibody diluted in the blocking buffer and 
incubate overnight at 4 °C. 
9. Wash 3X 10 min with the blocking buffer. 
10. Incubate for 5 hr at 4 °C with the secondary antibody diluted 1:500 in the blocking 
buffer in the humidifier chamber. 
11. Wash 3X 5 min with the blocking buffer. 
12. Mount onto a slide with 5-10 l Prolong plus DAPI. 
2.4 Gene cloning 
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Figure 2.1 shows the standard steps to clone a piece of DNA into a vector in E. coli. The 
vector DNA and the DNA fragment to be inserted into the vector are purified or 
amplified if needed and then digested, separated with enzymes by electrophoresis, 
recovered from agarose gel, and ligated together. Competent cells are transformed with 
the ligation mixture and selected for desired transformants. 
 
Figure 2.1: Standard steps for cloning. 
Plasmid DNA is extracted using a QIAprep miniprep kit from Qiagen or a GeneJET 
plasmid miniprep kit from Fermentas and stored at -20 °C. 
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Polymerase chain reactions (PCR) are used to amplify DNA. Purified genomic, plasmid 
or linear DNA is used as template. Typical reactions are performed in a total volume of 
50 l and contain 1X HF buffer coming with the polymerase, 0.6 M of each of forward 
and reverse primers ordered from IDT (Integrated DNA Technologies), 0.2 mM dNTPs 
from Invitrogen or NEB (New England Biolabs), 2% (v/v) DMSO, 1 l template DNA 
solution, and 1 U Phusion DNA polymerase from FINNZYMES. An Eppendorf thermal 
cycler is used to perform PCR. A typical PCR amplification using Phusion polymerase 
consists of an initial denaturation step at 98 °C for 30 sec, followed by 35 cycles of 
denaturation at 98 °C for 15 sec, annealing at 55 °C for 30 sec, and extension at 72 °C for 
30 sec for every kilo base of the amplified DNA, and then a final elongation step also at 
72 °C for 5 min. Touch-down PCR which has varied annealing temperature for the first 
10 cycles (from 45 °C to 65 °C) and normal (55 °C) for 25 cycles are used to amplify 
DNA fragments longer than 2 kb. All PCR products are purified using a QIAquick PCR 
purification kit from Qiagen or a DNA clean & concentrator-25 kit from ZYMO 
Research and are stored at -20 °C. 
Restriction enzymes are all purchased from NEB. For reactions with two enzymes, 2 l 
of each enzyme is added to a total volume of 50 l, which also contains 1X reaction 
buffer and BSA if needed. The mixture usually reacts at 37 °C for 4 hr. For enzymes not 
compatible with each other‟s reaction buffer or optimal temperature (some enzymes are 
most active at 50 °C or 55 °C), sequential digestion is performed, which means digest 
DNA with the first enzyme in its preferential buffer, purify to remove enzymes and salts, 
and then digest it with the second enzyme in its preferential buffer. 1 to 2 l of the 
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enzyme is used for these single enzyme digestions depending on the concentration of the 
enzyme. Usually 2 hr is enough for these reactions. 
A 1% low melt agarose (from Fisher) gel is used to separate DNA bands according to 
their size. Ethidium bromide is added to the gel with a final concentration of 0.5 g/l to 
facilitate the visualization of DNA. After being solidified, the gel is placed in 1X TAE 
buffer. Digested DNA samples are loaded with loading dye. Electrophoresis is performed 
under a voltage of 130 V for 20 to 30 min. Gel images with DNA bands can be obtained 
by exposure to UV light in a UV transilluminator. Cut out the band with the desired size 
and recover DNA from it using a DNA clean & concentrator-5 kit from ZYMO Research.   
Rapid ligation kits from Roche or Fermentas as well as T4 DNA ligase from Promega 
NEB have been used. They all work well and standard ligation reaction takes 30 min to 1 
hr. 1 l ligase, 1X buffer is added to a total volume of 20 l reaction system of the 
enzyme is used for these single enzyme digestions depending on the concentration of To 
obtain higher efficiency, the ratio of insert to vector is better to be higher than 5:1. The 
ligation mixture can be store temporarily at 4 °C for days. 
Host cells, usually E. coli Dh5α cells unless otherwise specified, can be transformed by 
heat-shock transformation or electroporation. (See details in 2.3 Protocols) 
Colonies on the transformation plate, if there is any, need to be checked by colony PCR 
using these colonies as template to check if it contains the desired gene with checking 
primers flanking the MCS (multiple cloning sites) on the vector or the cloning primers 
annealing to the gene and amplifying it. Taq polymerase from NEB or PCR green mix 
from Promega is used for colony PCR. Samples are run on an agarose gel to see if there 
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is a band and if the band size is right. Purification of the new plasmids from 
transformants and sequencing analysis can be performed if needed. In this work, DNA 
samples are submitted for sequencing to the Biotechnology Center Core DNA 
Sequencing Laboratory at the University of Illinois at Urbana-Champaign or the ACGT, 
INC. The obtained DNA sequence is aligned with the sequence it should be using 
ClustalW2 to confirm no unwanted mutations. 
2.5 Mutagenesis in E. coli 
2.5.1 Introduce mutations to a gene on plasmids 
Enzyme inverse PCR (EIPCR) is usually used to generate mutations on a plasmid 
(Figure 2.2).  
 
Figure 2.2: Point mutations introduced by EIPCR. 
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It has recognition sites (black square) for enzymes like BsaI (CGTCTCN/NNNN), 
BsmBI (GGTCTCN/NNNN), and BfuAI (ACCTGCNNNN/NNNN) on the ends of both 
the forward primer and reverse primer and sequences for mutations on the complimentary 
sticky ends (in green) after enzyme digestion. With these primers, EIPCR amplifies the 
whole plasmid except for the region to be mutated (in red) and generates linear DNA 
with the desired mutation and enzyme cutting sites. After enzyme digestion and re-
circularization, a new plasmid with the mutation is constructed and no enzyme sites are 
introduced. EIPCR can be used to introduce mutations as short as a few nucleotides and 
also works for deletion. To insert longer sequence up to 80 bp, the original plasmid is 
amplified using primers with the insertion sequence (in green) on the overhang. After 
kinase treatment of the blunt ends, they can be ligated together and generate a new 
plasmid with the insertion (Figure 2.3). 
 
Figure 2.3: Mutations introduced by inverse PCR and blunt end ligation.  
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2.5.2 Integration to E. coli genome 
Conditional-replication, integration, and modular (CRIM) plasmids are used to integrate 
DNA fragments in single copies into the chromosome of E. coli [1] (Figure 2.4). The 
CRIM plasmids all have a phage attachment site where recombination occurs with the 
same attachment site on the chromosome. They also have a resistance gene marker for 
selection and a MCS where DNA fragments can be cloned into. Another feature making 
the integration easier is that they have a R6K replication origin which requires the π 
protein for replication. This protein is absent in commonly used E. coli hosts like Dh5α 
and K12. An integration helper plasmid with ampicillin resistance marker is designed in a 
way that the gene encoding the π protein is under the control of a temperature sensitive 
promoter and only makes protein at 30 °C but not at higher temperature. To integrate a 
CRIM plasmid cloned with the target gene, first transform the host strain with the helper 
plasmid and grow it at 30 °C. Then transform cells containing the helper plasmid with the 
CRIM plasmid with the cloned gene and recover the cell first at 37 °C for 1 hr and then at 
42 °C for 30 min to eliminate the helper plasmid. Select with antibiotic resistance of the 
CRIM plasmid and cells that grow have to have at least one copy of the CRIM plasmid 
integrated into the chromosome. 
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Figure 2.4: Integration using CRIM plasmids. 
2.5.3 Gene knockout from E. coli chromosome 
Knockout of the chromosome genes is achieved through the Red disruption system. It 
includes three genes: γ, β, and exo encoding proteins Gam, Bet, and Exo, respectively. 
Gam inhibits the host RecBCD exonuclease V so that Bet and Exo can promote DNA 
recombination.  
A one-step knockout strategy based on this system works as follows [2]. First target cells 
are transformed with a helper plasmid with ampicillin resistance called pKD46 having 
this system under the control of the ParaB promoter. The plasmid pKD46 has a 
temperature sensitive replication of origin and cells with it need to be grown at 30 °C. 
Cells with pKD46 are grown overnight and then subcultured with a 1:100 dilution in LB 
media with 0.2% arabinose to make electro-competent cells. An antibiotic resistance gene 
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with flanking FRT (Flippase Recognition Target) sites, where recombination occurs 
between two FRT sites mediated by FLP (Flippase), is amplified from pKD3 or pKD4 
with primers having overhanging sequence identical to the adjacent genes of the target to 
be deleted (Figure 2.5). The PCR products, after cleanup, are used to transform the 
electro-competent cells. Cells are recovered for 2 hr at 37 °C and spread on plate with the 
proper antibiotic.  
Colonies are restreaked out on plate with the proper antibiotic and tested by colony PCR 
using primers bound outside the deleted region to make sure that the correct mutation was 
introduced. After the PCR check, colonies are grown on LB plates at 42 °C to eliminate 
pKD46 by testing ampicillin sensitivity, growing on LB plates but not on plates with 
ampicillin. 
To remove the antibiotic resistance marker from the mutated strains, the cells were 
transformed with the temperature sensitive plasmid, pCP20, which encodes FLP. The 
colonies on the ampicillin plates at 30°C were streaked on non-selective plate agar at 
42°C and then checked for the loss of antibiotics kanamycin/chloramphenicol and 
ampicillin. Prior to removal of the antibiotic marker, all mutations were moved into a 
wild-type background using P1 transduction. 
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Figure 2.5: Gene knockout from E. coli chromosome. 
2.6 Gene cloning in B. subtilis 
Not many plasmids can stay stable in B. subtilis, and so it is common to manipulate the 
chromosome when it comes to do gene cloning and expression in it. 
2.6.1 Integration 
In this work, several proteins of the chemotaxis pathways are fused to fluorescent protein 
to examine their subcellular localization especially in live cells. Three strategies are 
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developed to construct these fusion proteins and integrate them into the chromosome of 
proper B. subtilis strains, usually OI1085 and its derivatives. CheC is used as an example 
to illustrate these methods. 
The first strategy is to fuse the gene cheC and gfpmut3, a variant of gfp which is 
optimized for expression in B. subtilis, with a linker GGGGS first and then subclone the 
fused gene into a vector with the amyE integration sites for B. subtilis (Figure 2.6). Most 
of these vectors have an IPTG inducible promoter which can overexpress the genes 
downstream of it. Some vectors are promoter-less, a promoter usually the native one the 
gene is needed when cloning it. Linearize the vector with an enzyme having its cutting 
site outside the integration region and transform a B. subtilis host strain. Select integrants 
with the proper antibiotic resistance marker. The obtained colonies can be tested by 
starch plates to make sure it is double cross-over recombination and the amyE gene is 
disrupted.  
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Figure 2.6: Integration at the amyE site of B. subtilis chromosome. 
In the second strategy, a plasmid pMutin-GFPmut3 is built in this work by replacing yfp 
of pMutin-YFP from Bacillus Genetic Stock Center (BGSC) with gfpmut3. It has 
multiple enzyme cutting sites before gfpmut3. By cloning the last 300 bp of the cheC 
gene without the stop codon before gfpmut3, the resulted plasmid can recombine with the 
cheC gene on the chromosome. Good integrants can be selected with the proper 
resistance marker (Figure 2.7). 
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Figure 2.7: Integration using pMutin plasmids into B. subtilis chromosome. 
The third method is designed by Janes and Stibitz leaving no resistance marker after 
integration [3]. The vector has an 18 bp cutting site recognized by the enzyme I-SecI.  In 
this work, the gene gfpmut3 without stop codon was inserted into the MCS of this vector 
and allows for GFPmut3 fused to either the N-terminus or C-terminus of a target protein. 
Figure 2.8 shows the strategy to construct cheC-gfpmut3 using this method. The gene 
cheC without the stop codon was cloned upstream of gfp and the gene cheD, which is 
downstream of cheC on the chromosome, together with a stop codon before it was cloned 
right after gfp. Transform a B. subtilis strain, recombination can happen at ① or ② or 
both. In case of single cross-over recombination like ① or ②, the chromosome is 
linearized by expressing the enzyme I-SecI controlled by a temperature sensitive 
promoter on a helper plasmid which is transformed and expressed at 30 °C in this step. 
To survive, the chromosome DNA has to re-circularize by recombining at ③ or ④, 
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resulting in a strain either identical to the old chromosome or the desired one with cheC-
gfp. Elevating the temperature to 42 °C for 30 min when transforming the helper plasmid 
can easily cure it. Counter select colonies not growing on ampicillin plates first to make 
sure the helper plasmid is removed and then with the resistance marker the vector carries. 
Colonies that do not grow on the plate with respective resistance are 50% likely the ones 
we want. Further analysis by PCR using chromosome DNA is needed. Colonies that 
grow out are those when double cross-over recombination occurs at the beginning, but 
the chance is really low. 
Strategy one allows the fluorescent protein to be fused at either N-terminus or C-terminus 
of the target protein and the fused gene can be controlled by its native promoter or an 
inducible one. Strategy three also allows the fusion at both ends controlled by its native 
promoter and leaves no resistance marker. But the cloning process is tedious and time-
consuming. Strategy two is easier to carry out requiring a one-step cloning and a simple 
transformation to B. subtilis cells, although it only generates C-terminus fusion controlled 
by the native promoter. All the integrated fusion proteins need to be tested for their 
functionality by comparing new strains with the original ones of their chemotactic 
behavior using either swarm plate assay or more accurate ones like capillary assay or 
tethering.  
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Figure 2.8: Markerless gene replacement in B. subtilis. 
2.6.2 Gene knockout 
A straightforward way to delete a gene from the chromosome is to replace it with an 
antibiotic resistance gene. Clone the upstream and downstream genes of the target gene 
into a vector in a way that these two genes flank an antibiotic resistance gene (Figure 
2.9.A). Selecting with the antibiotic, linearized vector has to recombine with the 
chromosome at both of the genes, resulting in the deletion of the target gene. 
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Figure 2.9: Gene knockout in B. subtilis. 
Another method is similar to the strategy using vectors having I-SecI site and results in 
markerless deletion of a gene [3] (Figure 2.9.B). 50% of colonies counter-selected at the 
end are the ones with the target gene deleted and PCR test is needed to confirm this. This 
method, although time-consuming, is quite useful in case that further cloning and 
integration is needed and a markerless strain is more convenient.  
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Chapter 3: The Role of CheV in Adaptation 
3.1 Introduction 
All bacteria appear to employ for chemotaxis a modified two-component system to sense 
and respond to chemicals, where the receptors form ternary complexes with the CheA 
histidine kinase and the CheW adaptor protein [1,2]. The clustering of these ternary 
complexes into semi-ordered hexagonal lattices has been documented in multiple 
organisms [3] and is presumably conserved in all species of chemotactic bacteria. 
Clustering, however, is not necessary for receptor-mediated kinase activation as a single 
receptor dimer is sufficient for modulating kinase activity in response to attractant 
binding [4]. Rather, these arrays are thought to amplify the response to ligand binding 
[5,6]. A number of models have specifically proposed that cooperative interactions 
between the receptors within these arrays enable bacteria to sense small differences in the 
number of ligand-bound receptors over a wide range of concentrations (see [7]). 
While multiple studies have investigated the structure and molecular determinants of 
these clusters (e.g. [8,9]), little is known about how they respond to attractant binding and 
facilitate signaling aside from a few notable studies. Recently it was found in Escherichia 
coli that the activity of the CheA kinase increases as the receptors density increases 
[10,11]. Similarly, attractant binding, which inhibits kinase activity in E. coli [12], has 
been shown to increase the separation between the receptors [13,14]. Using multivalent 
ligands that alter the packing of receptors within the cluster, the Kiessling laboratory has 
shown that attractants have a destabilizing effect and repellents a stabilizing one [15,16]. 
Consistent with this model, Lamana and coworkers [17] found using 
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immunofluorescence that the binding of nearly saturating concentrations of attractant 
disrupts the polar localization of the chemotaxis receptors in both E. coli and B. subtilis. 
Prior to the addition of attractant, they found that the receptors were clustered at the cell 
poles in the majority of the cells analyzed (>80%), consistent with previous observations. 
Interestingly, soon after exposing the bacteria to attractant, they observed a significant 
and marked decrease in the number of cells where the receptors were clustered. In 
particular, in a sizeable fraction of cells (>40%), they observed no clustering whatsoever. 
However, once the cells adapted to the attractant, polar clustering was restored in the 
majority of the cells. Collectively, these observations argue for a model where attractant 
binding decreases the packing of the receptors within the semi-ordered lattices at the cell 
poles, leading to more fluid associations between the receptors and a reduction in the 
degree of clustering [10,17]. 
 
Figure 3.1: The two domains of CheV. 
In addition to clustering, receptor signaling in bacterial chemotaxis may also be regulated 
by modulating the interactions between the receptors and the kinase. Support for such a 
mechanism comes from CheV, a hybrid protein with an N-terminal CheW-like adaptor 
domain and a C-terminal response regulator domain that is known to be phosphorylated 
by CheA [18,19,20] (Figure 3.1). This protein is believed to function in a separate, 
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methylation-independent adaptation system [19,21]. First discovered and characterized in 
B. subtilis [19,22], CheV has subsequently been found in numerous other bacteria 
including Salmonella enteric but not E. coli [23,24,25,26]. Interestingly, in the gastric 
pathogen Helicobacter pylori, the single adaptation system employs three CheV 
paralogues but not reversible receptor methylation [20,27]. Despite its prevalence, little is 
known about how this protein functions in chemotaxis beyond the requirement for 
phosphorylation.  
As CheV is functionally similar to CheW, we previously hypothesized that it dynamically 
regulates the coupling between the receptors and the CheA kinase as part of a 
methylation-independent adaptation system [21]. In the present study, we tested this 
hypothesis in B. subtilis by tracking the proximal location of the receptors and CheV 
during the excitation and adaptation to attractant using immunofluorescence. Our results 
demonstrate that, prior to excitation with attractant, the receptors are predominantly 
clustered at the poles in most cells.  When the cells are initially excited with attractant, 
we found that the receptors localize to lateral clusters distinct from the ones at the pole in 
many cells. When the cells adapt to the attractant, the receptors are again localized 
predominantly at the poles of the cell. Interestingly, we found that CheV is 
predominantly localized at lateral clusters on the sides of the cell. Upon excitation with 
attractant, however, CheV migrates from the lateral clusters to ones at the pole. This 
transition is reversible, as CheV returns to the lateral clusters once the cells adapt. 
Interestingly, the redistribution of CheV is phosphorylation dependent: deleting the 
response regulator domain or mutating the phosphorylation site causes CheV to localize 
primarily at the cell poles, irrespective of attractant. Based on these results, we are able to 
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propose a model for the dynamic regulation of the chemotaxis signaling arrays in B. 
subtilis. 
3.2 Results 
3.2.1 Localization of chemotaxis receptors 
 
Figure 3.2: Changes in McpB localization upon excitation and adaptation to 
attractant. 
Based on the observations of Lamana and coworkers [17], we imaged receptor 
localization in B. subtilis using a similar methodology. However, we refined their 
analysis to account for recent observations in E. coli regarding the positioning of the 
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receptor clusters. While the majority of receptors are localized at the poles in E. coli, 
many are also found in distinct clusters laterally along the length of the cell 
[8,9,28,29,30,31]. Consistent with previous results [17,32], we found that McpB, the sole 
chemotaxis receptor for the attractant asparagine [33], was localized at the cell poles in 
the majority of B. subtilis cells (Figure 3.2). However, when we exposed the cells to 
nearly saturating concentration of asparagine (1 mM), we observed a significant 
reduction in the number of cells exhibiting polar receptor localization and an increase in 
the number exhibiting lateral receptor clusters (Figure 3.3). Once we allowed the cells to 
adapt, polar localization was restored. These results suggest that attractant binding not 
only destabilizes polar receptor clustering, as previously proposed, but also induces the 
formation of lateral clusters by some unknown mechanism. 
 
Figure 3.3: Examples of different localization patterns. 
53 
 
The differences between the present and previous results are likely due to how the cells 
were prepared and the fluorescence images collected and processed. In particular, we 
included an additional blocking step prior to incubating the permeabilized cells with 
antibody. We also preabsorbed the antibody several times against the corresponding 
knockout strain to reduce non-specific binding. These steps significantly reduced 
background fluorescence. In addition, we acquired our images as Z-stacks and were thus 
able to reduce the background signal and noise by 3D deconvolution. Collectively, these 
modifications afforded higher resolution imaging of the cells, enabling us to observe 
patterns of receptor localization not otherwise possible (Figure 3.4). Specifically, the 
diffuse staining previously observed is likely due to the formation of lateral clusters. As a 
consequence, we were able to extend and refine the observations concerning McpB 
localization made by Lamana and colleagues [17].  
 
Figure 3.4: Comparison of images using different protocols.  
3.2.2 Determinants of the receptor clusters 
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Figure 3.5: Effect of CheW, CheV, and CheA on the localization of McpB.  
CheW is known to affect receptor clustering in E. coli and B. subtilis [8,9,17]. Consistent 
with these previous observations, we found that McpB localized at polar clusters in fewer 
cells when CheW was no longer present (Figure 3.5). In addition, inspection of the 
McpB staining patterns revealed that the polar clusters were more diffuse in a cheW null 
mutant and did not exhibit the punctuate spots seen in wild-type cells (similar punctuate 
spots are also observed in wild-type E. coli [9]). Conversely, loss of CheV or CheA was 
found not to affect polar localization. As CheV is predominantly localized at the lateral 
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clusters and not the polar ones, these results are entirely expected; deleting the protein 
would not be expected to affect the polar clusters. In the case of CheA, we found that the 
loss of this protein did not affect polar localization though inspection of these clusters 
revealed that they were more diffuse. Similar results are also observed in E. coli. [9,34] 
3.2.3 Movement of CheV in the process of excitation and adaptation 
CheW is a scaffold protein, found in all chemotactic bacteria, that facilitates the coupling 
between CheA and the chemotaxis receptors [35,36]. CheV, a hybrid protein consisting 
of an N-terminal CheW-like domain and C-terminal response regulator domain, is 
functionally redundant to CheW in B. subtilis: loss of either protein does not prevent 
adaptation but does lead to a minor reduction in chemotaxis efficiency [19,22]. Loss of 
both proteins, however, completely abrogates chemotaxis.  Previously, we hypothesized 
that CheV functions in a methylation-independent adaptation system where the 
phosphorylation of its response regulation domain inhibits the coupling between CheA 
and the receptors [21]. Such a model could explain how CheV functions in a distinct 
adaptation system. However, this model was formulated under the assumption that 
receptor clusters are static entities as opposed to in fact being dynamics ones. 
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Figure 3.6: CheV localization upon excitation and adaptation to attractant.  
Our previous results regarding the dynamic localization of the receptors led us to 
hypothesize that CheV may somehow be involved in this process. To image CheV 
localization, we used again immunofluorescence, employing the same procedure used to 
track the dynamic localization of McpB (Figure 3.6). To our surprise, we found that 
CheV was not localized at the poles in most cells but rather at lateral clusters. 
Remarkably, when the cells were stimulated with asparagine, we found that CheV was at 
the poles in most cells. Once the cells adapt, CheV was again mostly localized in lateral 
clusters. These results suggest that CheV may move from the lateral clusters to the polar 
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ones in response to the addition of attractant, a migration pattern that is opposite to what 
is observed for McpB.  
 
Figure 3.7: Effect of CheV on McpB localization dynamics. 
To determine whether CheV has an effect on the movement of the receptors, we tracked 
the dynamic localization of McpB in a cheV null mutant (Figure3.7). Comparison to our 
wild-type results showed that there was a mild decrease in the number of cells exhibiting 
polar clusters. These polar clusters, however, were more stable in the cheV null mutant as 
few cells exhibited lateral clusters or diffuse staining upon addition of attractant. In 
addition, the fraction of cells exhibiting polar clusters did not completely return to 
prestimulus levels upon adaptation to asparagine. The results suggest that CheV may 
promote the disruption of the polar clusters and also aid in adaptation as previously 
hypothesized [19,21]. 
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Figure 3.8: CheW localization upon excitation and adaptation to attractant.  
We also performed similar localization studies with CheW (Figure 3.8). Unlike CheV, 
we found that CheW was predominantly localized at the cell poles. Moreover, the spatial 
distribution of CheW did not change upon exposure to asparagine. If anything, we saw an 
increase in the degree of polar localization. Collectively, these results suggest that CheV 
is not a static protein, as is the case with CheW, but rather a dynamic one that spatially 
redistributes during excitation and adaptation in a manner opposite to the receptors.  
3.2.4 Changes in CheV localization are phosphorylation dependent 
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Figure 3.9: Percentage of cells exhibiting different localization patterns for 
CheV in a cheVD385A point mutant. 
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Figure 3.10: Percentage of cells exhibiting different localization patterns for 
CheV in a cheV1-168 truncation mutant. 
During the initial characterization of CheV, phosphorylation of this protein was found to 
be necessary for adaptation: mutants of B. subtilis where CheV cannot be phosphorylated 
- either because the phosphorylation site was mutated to an alanine residue or because the 
whole response regulator domain was deleted - do not adapt following addition of 
attractant [19]. We, therefore, hypothesized that the phosphorylation of the CheV 
response regulator domain may control its movement. Consistent with our hypothesis, we 
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found that mutating the phosphorylation site to an alanine (Figure 3.9) or deleting the 
response regulator domain in its entirety (Figure 3.10) inhibits the redistribution of this 
protein upon stimulation by asparagine. In both mutants, we found that CheV was 
predominantly localized at the cell poles, irrespective of whether asparagine was added. 
While some minor changes were observed in the case of the point mutant, deletion of the 
response regulator domain made CheV static. The results indicate that the dynamic 
localization of CheV is phosphorylation dependent. 
3.2.5 CheW inhibits the transient polar localization of CheV 
 
Figure 3.11: Effect of CheW on CheV localization. 
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Figure 3.12: Effect of CheV on CheW localization. 
As CheW and CheV are functionally redundant [19], we next tested how CheW affects 
CheV localization (Figure 3.11). Prior to stimulation with asparagine, we did not observe 
any significant difference in CheV localization patterns in a cheW null mutant relative to 
the wild type. Upon stimulation with asparagine, we again observed that CheV was 
predominantly localized at the poles. However, we found that CheV was polarly localized 
in a slightly higher percentage of cells as compared to the wild type (55% versus 45%). 
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These results suggest that CheW may hinder the movement of CheV to the poles by 
competitively inhibiting the binding of CheV to the receptors and CheA. When we 
performed reciprocal experiments, however, we found that CheV had no effect on the 
CheW localization (Figure 3.12); CheW was predominantly localized at the cell poles 
and was unaffected by asparagine in a cheV null mutant. 
3.3 Discussions 
We observed unexpected localization dynamics of the chemotaxis proteins in B. subtilis. 
The original motive for undertaking these experiments was to attempt to gain a better 
understanding of CheV; however, our results also revealed novel information concerning 
the effect of attractant binding on receptor localization and clustering. In accordance with 
the results of Lamana and coworkers [17], we found that McpB, the sole chemotaxis 
receptor for the attractant asparagine, is primarily localized at the cell poles prior to 
stimulation with attractant. Upon the addition of nearly saturating concentrations of 
asparagine, McpB leaves the poles in many cells. However, in this study, we found that 
the receptors do not randomly redistribute along membrane but rather move to distinct 
clusters along the lateral length of the cell. This process is reversed once the cells adapt, 
with the receptors returning to the cell poles. Moreover, we found that CheV is 
predominantly located in lateral clusters prior to stimulation with asparagine. When the 
cells are stimulated with asparagine, CheV apparently moves from these lateral clusters 
to ones at the pole in a pattern of migration opposite to what is observed with the 
receptors. As with the receptors, this process is reversible with CheV found again 
predominantly at the lateral clusters once the cells adapt. Most intriguing, we found that 
the movement of CheV is phosphorylation dependent, where mutation of CheV‟s 
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response regulation domain fixes the protein at the cell poles. These results further 
demonstrate that the chemotaxis signaling arrays are not static structures but instead 
dynamic ones that spatially reorganize in response to the binding of attractant. Moreover, 
they demonstrate that the localization of some proteins, CheV in particular, is 
dynamically regulated.   
3.3.1 A model for dynamic receptor localization 
Multiple studies have observed lateral receptor clusters in E. coli [8,9,28,29,30,31]. 
While the role of these lateral clusters is still unknown, their positioning along the cell 
does not appear random, suggesting that they associate to specific cellular landmarks. In 
one notable study, Theim and coworkers [31] observed that these later clusters in E. coli 
are found along defined positions in the cells with a fixed periodicity. In addition, they 
found that these clusters apparently associate at positions that mark future division sites 
within the cell. While we have not performed a detailed investigation of lateral cluster 
positioning in B. subtilis, our data is certainly consistent with the model proposed by 
Theim and coworkers. We note that an alternate, equally plausible mechanism has also 
been proposed [28,37], where the apparent periodicity of these clusters is due to 
stochastic nucleation and not prescribed landmarks. Regardless of the mechanism, the 
positioning of these lateral clusters still does not explain why the receptors move to them 
upon the addition of attractant and back to the poles when the cells adapt. 
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Figure 3.13: A model of dynamic localization of chemotaxis proteins.  
Based on our results, we imagine that B. subtilis cells possess a number of anchoring sites 
for the receptors that are positioned along the cell length (Figure 3.13). The receptors 
have differential affinity for these sites with most affinity for the polar sites. Each site can 
only support the binding of a limited number of receptors. However, cooperative 
interactions among the receptors enable more to cluster at the preferred polar sites than 
would be otherwise supported in the absence of these interactions. This leads to the 
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receptors predominantly clustering at the poles instead of at the sides. The binding of 
attractants, however, increases the spacing between the receptors with the effect of 
breaking the cooperative interactions between them. As the preferential sites at the poles 
can no longer support the clustering of all these receptors due to the loss of these 
interactions, many receptors relocate to the lateral sites by a passive diffusion mechanism. 
However, when the cells adapt to the addition of attractant, these interactions are restored, 
enabling the receptors to return to their preferential sites at the poles. This hypothetical 
mechanism would explain our observations regarding dynamic receptor localization, 
though it is not clear whether diffusion is sufficiently fast to enable the sampling of 
different sites by the receptors. This model would also predict that a sizable fraction of 
receptors is constantly diffusing in the membrane, transiently binding to different sites 
and clusters. 
3.3.2 A model for CheV dynamic localization 
We propose that CheV will preferentially bind the receptors when they are in a more 
diffuse configuration and not clustered in tight aggregates. Such a mechanism would 
explain why CheV moves from the sides to poles when the cells are excited with 
attractant and back again when they adapt. In both unstimulated and adapted cells, CheV 
preferentially localizes to the lateral sites. We imagine the receptors there are less dense 
than those at the poles (see Figure 3.13), perhaps in part because less CheA is located 
there (see below). In stimulated cells, CheV preferentially localizes to the poles. We 
imagine that attractant binding destabilizes the receptors there. The associated reduction 
in density increases the affinity of CheV for the remaining polar receptors. At the very 
least, CheV has equal affinity for the receptors at the pole and the sides in stimulated 
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cells; the receptor density at the lateral sites if anything increases (Figure 3.13). Most 
likely, these localization patterns are not static but rather dynamic with CheV constantly 
shuttling between the two locations by a passive diffusion mechanism. 
 
Figure 3.14: CheA localization upon excitation and adaptation to attractant.  
This model, however, is not complete as our data demonstrate that additional factors are 
also involved. In particular, CheV has different affinities for the receptor clusters at the 
sides and poles depending on whether it can be phosphorylated or not. Insight regarding 
how CheV can discriminate between these different sites comes from the distribution of 
CheA, as the vast majority of this protein is found at the poles irrespective of whether 
asparagine is added or not (Figure 3.14). To explain our results involving the 
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phosphorylation mutants of CheV, we propose that phosphorylated CheV is more apt to 
complex with free receptors than with receptors already bound to CheA. Likewise, 
unphosphorylated CheV is more apt to complex with receptors already bound to CheA 
than with free receptors. Given the distribution of CheA, this model predicts that 
phosphorylated CheV is primarily localized at the lateral sites whereas unphosphorylated 
CheV is primarily localized at the poles. This model would explain why the 
phosphorylation mutants of CheV are located at the poles if we assume they behave like 
unphosphorylated CheV. To explain how phosphorylation affects dynamic localization, 
we first note that attractant binding increases CheA activity in B. subtilis [38] as opposed 
to repressing it in E. coli [12]. During adaptation, the fraction of phosphorylated CheV 
increases, though at a much slower rate than for CheY [19]. Phosphorylation causes 
CheV to be excluded from the poles. In terms of a mechanism, phosphorylated CheV 
likely both disrupts the coupling between the receptors and CheA and decreases the 
stability ternary complex, since phosphorylated CheV migrates to the sides where CheA 
is much less present and where the receptors are increasingly becoming less dense as 
cells slowly adapt to the attractant.  
One last finding concerns McpB localization dynamics in a cheV null mutant. As we have 
noted, the polar clusters are less affected by attractant in a cheV null mutant than in wild 
type. In the context of our model, we imagine that the binding of CheV to the receptors 
promotes a more diffuse receptor configuration. In the absence of CheV, we would 
expect then that the receptor clusters are more stable (i.e. tightly packed) and less prone 
to disruption by attractant binding. This mechanism would also predict that the CheV 
phosphorylation mutants, which we imagine promote even a more diffuse configuration, 
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enhance receptor-mediated kinase activation. Indeed, cheV phosphorylation mutants fail 
to adapt to the addition of attractant [19]. The kinase activities in these mutants remain 
elevated upon attractant addition and do not return to prestimulus levels.  
We conclude by noting that CheV is involved in a methylation-independent adaptation 
system in B. subtilis and potentially other bacteria as well. Based on our proposed model, 
unphosphorylated CheV likely has a positive effect on CheA activity as it promotes a 
diffuse receptor configuration. However, when it becomes phosphorylated, CheV inhibits 
CheA activity as it disrupts the coupling between the receptors and CheA. In addition, 
phosphorylated CheV is less prone to bind receptors and CheA, further limiting the 
coupling necessary for kinase activation. Such a mechanism would imply that CheV 
functions in a negative feedback loop with CheA. While a similar feedback mechanism 
has been postulated in past [19,21], the significant finding here is that it is spatially 
regulated. 
3.4 Materials and methods 
3.4.1 Strains and growth conditions 
All Bacillus subtilis strains are isogenic derivatives of the chemotaxis wild-type strain 
OI1085 (che
+
, ilvC1 leu-1 trpF7 hisH2 metC1) [39] and have been described previously 
(see Table 3.1). All strains were grown in minimal media (50 mM K3PO4, 1.2 mM 
MgCl2, 1 mM (NH4)2SO4, 140 μM CaCl2, 10 μM MnCl2, 20 mM sorbitol, 50 ug/ml 
histidine, 50 ug/ml methionine, and 50 ug/ml tryptophan) to early stationary phase (180-
200 Klett Units).  
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Table 3.1: Bacillus subtilis strains used in this study. 
Strain Relevant genotype or description Reference 
OI1840 cheA::cat [40] 
OI2737 cheW::cat [41] 
OI3059 cheV::kan [22] 
OI3446 cheV::kan, thrC::cheVD235A [19] 
OI3450 cheV::kan, thrC::cheV1–168 [19] 
OI3545 Δ10mcp [42] 
 
3.4.2 Fluorescence microscopy 
Bacteria were fixed for 15 minutes at room temperature and 30 minutes on ice in 2.5% 
paraformaldehyde (Ted Pella, CA). Fixed bacterial cells were than plated onto poly L-
lysine coated glass coverslips, and excess cells were removed after ten minutes. The 
coverslips were then washed three times for five minutes each time in phosphate buffered 
saline (PBS) containing2% bovine serum albumin (BSA). The cells were treated with 
lysozyme (0.1 μg/ml) for twenty minutes. The coverslips were washed again three times 
for ten minutes with PBS containing 2% BSA and incubated overnight at 4˚C in primary 
antibody diluted into PBS containing 2% BSA. The primary antibody anti-McpB was 
used at a dilution of 1:500, anti-CheA at a dilution of 1:2000, anti-CheV at a dilution of 
1:1000, and anti-CheW at a dilution of 1:5000.  All antibodies were pretreated six times 
by acetone powder pre-absorption using their corresponding knockout strains: OI3545 
(Δ10mcp) for anti-McpB, OI1840 (ΔcheA) for anti-CheA, OI3059 (ΔcheV) for anti-CheV, 
and OI2737 (ΔcheW) for anti-CheW to reduce background signals caused by non-specific 
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binding. After overnight incubation with the primary antibodies, the coverslips were then 
washed three times for ten minutes with PBS containing 2% BSA and then incubated for 
five hours at 4˚C in with a goal anti-rabbit antibody labeled with FITC (Molecular Probes) 
at a dilution of 1:500 in PBS containing 2% BSA. Finally, the coverslips were washed 
three times for five minutes in PBS containing 2% BSA and mounted onto slides using 
Prolong with DAPI (Molecular Probes). Prolong was allowed to dry completely, 
eliminating the need to seal the coverslips to the slides. 
The fixed cells were imaged using a Zeiss Axiovert 200M inverted microscope equipped 
with a Zeiss Apotome structured illumination system. Images were acquired using a 
Roper Scientific Cascade 512B EM CCD camera. In each field of view, 0.25 μm optical 
sections were collected through the Z axis. Each image was than deconvolved using 
AutoQuant X software (Media Cybernetics). For each sample, at least 100 cells were 
randomly picked from several different fields. Cells were analyzed quantitative by 
graphing fluorescence intensity along longitudinal and multiple traversal axes. Cells were 
then classified based on their localization pattern.  
3.4.3 Image analysis 
The secondary antibody used is conjugated to a FITC (green) fluorophore.  This green 
signal, therefore, corresponds to the signal of interest within cells.  This signal was 
classified as being; polar, lateral, diffuse, or both polar and lateral.  Classification of the 
fluorescence signal location was determined using the 2-D fluorescence quantitation 
feature available in the AutoQuant X software package (Media Cybernetics). 
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Figure 3.15: Sample field of view. 
For each sample, several different fields of view, each containing multiple cells, were 
recorded using an EM-CCD camera.  Any region showing fluorescence within the field 
of view was isolated and enlarged (Figure 3.15).  The enlarged region of interest was 
visually inspected to ensure it contained both a DAPI and FITC signal.  The presence of a 
DAPI signal (which labels nucleic acids, primarily DNA) within the region of interest 
confirms the presence of cells and the presence of a FITC signal indicates that the target 
protein is present within that cell. In the event that either the DAPI or FITC signal was 
missing, the region of interest was eliminated from further analysis.  
73 
 
 
Figure 3.16: Quantitation of fluorescence intensity along longitudinal axis.  
A. Construction of longitudinal “quantitation” line on two sample cells. B. Fluorescence 
signal along longitudinal “quantitation” line. Blue denotes DAPI signal and green denotes 
FITC signal. 
Next the region of interest was imported into the AutoQuant software package and a 
“quantitation” line was drawn along the longitudinal axis of the cell, denoted by X in the 
figures (Figure 3.16). The AutoQuant software quantifies the fluorescence intensity for 
each different fluorophore present along the “quantitation” line.  This information was 
plotted on a graph with the FITC fluorescence signal represented as a green line and 
DAPI fluorescence signal represented as a blue line. The x-axis of the graph corresponds 
to the X “quantitation” line along the longitudinal axis of the cell.  
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Figure 3.17: Example of cells displaying different localization patterns.  
A. Polar localization. B. lateral localization. Blue denotes DAPI signal and green denotes 
FITC signal. 
The length of the cell was determined using the AutoQuant software. Once the length of 
the cell was determined, we divided the cell into 6 equal pieces by drawing 5 
“quantitation” lines running perpendicular to the original ”quantification” line X. These 
lines denote the traverse axis of the cell and are labeled Y1 through Y5, respectively 
(Figure 3.17 A & B). In the event that the top of the cell cannot be precisely determined 
lines Y1 and Y5 are chosen such that the peak DAPI fluorescence along Y1 and Y5 is 
approximately 25% of the most intense DAPI along line X. The FITC and DAPI 
fluorescence intensity were graphed along each of the five traversal “quantitation” lines 
Y1-Y5.   
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The fluorescence staining pattern within cells was classified based on the fluorescence 
intensity observed along lines X, and Y1-Y5.  Each cell was treated individually for 
quantification purposes. Based on this analysis, cells were classified as having either 
polar, lateral, diffuse or both polar and lateral localization. First, the fluorescence plotted 
along “quantitation” line X was examined. The number of peaks visible for the DAPI 
(blue) fluorophore along the X line represented how many individual DNA genomes 
were present within the region of interest.  We equated individual DAPI peaks in 
fluorescence intensity as independent cells, assuming that the DAPI peak denotes an 
individual genome. DAPI peaks were identified as distinct from one another if there was 
a region of “zero” fluorescence between them. If two DAPI peaks were visible but there 
was still a DAPI signal connecting the two, then this was considered to be one DAPI 
signal and was not treated as a distinct cell. If cells were too closely located to be treated 
separately or distinct DAPI signal could not be distinguished, then the region of interest 
was eliminated from further analysis.  
Next, the FITC signal was examined along the X and Y1-Y5 lines to classify the 
localization pattern. If the FITC signal was present along all quantification lines, then the 
cell pattern was classified as diffuse.  If the FITC fluorescence showed 2 peaks along the 
X line, as well as one or more peaks along the Y1 line and/or one or more peaks along the 
Y5 line but no peaks along the Y2-Y4 lines, then the cell pattern was classified as polar. 
For the purpose of this study, no distinction was made between cells exhibiting a “polar 
cap” and cells exhibiting 2 or more distinct spots localized to the poles [29]. Likewise, no 
distinction was made between cells that exhibited FITC signal at just one pole versus 
those that had FITC signals at both poles. In other words, we did not distinguish between 
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cells having a single polar cluster at one versus cells having them at both ends [43].  If 
the FITC signal showed one or more peaks along at X line and no peaks along the Y1 or 
Y2 lines along with a peak in any or all of Y2-Y4 lines, the cell pattern was classified as 
lateral. If the FITC signal showed two or more peaks along the X quantification line and 
showed one or more peaks in along the Y1 and/or Y2 lines along with one or peaks along 
the Y2-Y4 lines, then the localization pattern was classified as both polar and lateral. 
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Chapter 4: The Role of Configuration and Coupling in 
Autoregulatory Gene Circuits 
4.1 Introduction 
Complex arrays of regulatory gene circuits enable cells to efficiently utilize resources and 
respond to changes in their environments. Analysis of these circuits in a variety of 
organisms has identified a number of recurring regulatory mechanisms or so-called 
network motifs  [1,2] (Figure 4.1).  
 
Figure 4.1: Network motifs. 
Perhaps the simplest motif found in these circuits is autoregulation, where a given 
transcription factor regulates its own expression along with the expression of target 
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structural genes (i.e. genes not directly involved in regulation). The feedback loops 
formed in these autoregulatory gene circuits can be either negative or positive, where the 
transcription factor either represses or activates its own expression (Figure 4.2).  
 
Figure 4.2: Autoregulatory feedback loops. 
R denotes genes encoding for regulator, usually transcriptional factors; S denotes genes 
encoding for non-regulating proteins, usually structural proteins or enzymes. 
Both forms of control are ubiquitous and have been shown to have a variety of roles. 
Negative autoregulation, for example, has previously been shown to speed up the 
response time of gene circuits, reduce variation in protein expression levels, and linearize 
the dose response [3,4,5,6]. Positive autoregulation, on the other hand, has been shown, 
for example, to generate bistability and amplify gene expression [7,8,9,10,11]. In addition, 
the optimal mode of regulation, positive or negative, is thought to depend on a range of 
design parameters related to, for example, the gain, expression capacity, and 
responsiveness of the circuit [12]. Examples of more complex motifs include feed-
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forward loops, single-input modules, and double positive/negative feedback loops [1,13]. 
In addition to the specific regulatory mechanism employed, the behavior of a circuit may 
also be determined by how it is physically encoded within the genome. By physical 
encoding, we mean the orientation and relative proximity of a transcription factor to its 
target structural genes. In particular, a given regulatory mechanism involving multiple 
genes can be physically arranged in any number of ways. The specific location of the 
genes may, therefore, represent an additional factor determining circuit behavior. In other 
words, two circuits involving the same genes and general regulatory mechanism can 
potentially behave differently if they are physically encoded in alternate configurations. 
In the case of bacteria, an autoregulatory circuit involving a transcription factor and its 
target structural gene may be organized in at least three different configurations (Figure 
4.3). In the first, which we term the tandem configuration, both the transcription factor 
and structural gene are encoded in the same operon and transcribed as a polycistronic 
mRNA from a single unidirectional promoter. In the second, which we term the 
decoupled configuration, the transcription factor and structural gene are encoded in 
different operons and transcribed as monocistronic mRNAs from two independent, 
unidirectional promoters. In the third, which we term the divergent configuration, the 
transcription factor and structural gene are encoded in different operons and transcribed 
as monocistronic mRNAs, as is the case in the decoupled configuration. However, 
transcription proceeds in opposite directions along both the positive and negative DNA 
strands from either a single divergent promoter or two closely spaced promoters in 
opposite orientations. 
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Figure 4.3: An autoregulatory gene circuit arranged in different 
configurations. 
In this work, we investigated how the transcriptional organization of a negatively 
autoregulated gene circuit can affect its behavior. Using the tetRA circuit from transposon 
Tn10 as the basis for our comparison, we compared the dose-response behavior of this 
circuit when it was arranged in either a divergent, decouple, or tandem configuration. 
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Mathematical modeling predicted that when the circuit was arranged in a divergent or 
decoupled configuration, it had a lower cost relative to the one arranged in the tandem 
configuration in the sense that less repressor protein is needed to fix the expression 
capacity of the circuit. Moreover, we found that by reducing the concentration of the 
repressor the expression of the structural gene was more sensitive to inducer, as less is 
required to titrate and inactivate all of the repressor. We experimentally validated these 
predictions by measuring the response to inducer of synthetic gene circuits based on the 
tetRA circuit arranged in these three configurations. Collectively, these results provide 
one example of how the physical topology of a gene circuit can influence its behavior in 
addition to the general feedback mechanisms employed. 
4.2 Results 
4.2.1 Analysis of transcriptional organization of autoregulatory gene 
circuits 
To understand how autoregulated gene circuits are organized, we analyzed all known 
transcription factors in the E. coli K-12 genome using RegulonDB as the reference [14]. 
Of the 167 annotated transcription factors, we focused on the 99 thought to regulate their 
own transcription. Based on the analysis of data from RegulonDB, EcoCyc [15], and 
proximal genomic regions [16], we were able to categorize these autoregulators into four 
types according to their transcriptional organization (Figure 4.4).  
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      B.  
Figure 4.4: Transcriptional organization of autoregulatory gene circuits and 
their relative abundance in E. coli. 
A. Transcriptional organization of autoregulatory gene circuits in E. coli. In all cases, R 
denotes the regulator and S the structural genes that it regulates. a. The regulator and the 
structural genes are transcribed in a divergent configuration. b. The regulator and 
structural genes are transcribed in a tandem configuration. c. The regulator and some 
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structural genes are transcribed in a divergent configuration whereas the other structural 
genes are transcribed with the regulator in a tandem configuration. d. The regulator is 
transcribed from a single promoter. Note that in many cases the regulator controls the 
expression of additional structural genes from uncoupled promoters. B. Relative 
abundance of different transcriptional configurations in E. coli based on analysis of 
transcription factors that are either known or predicted to regulate their own expression. 
Results from our analysis found that: a) 24 (24.2%) E. coli autoregulators are transcribed 
in a divergent configuration, where the autoregulator is on one side of the promoter and 
the target structural genes are on the other side; b) 31 (31.3%) are transcribed in a tandem 
configurations, where both the autoregulator and structural genes are in the same operon; 
c) 15 (15.2%) are transcribed in a hybrid configuration involving a divergent promoter, 
where the autoregulator is on one side and the target structural genes are present on both 
sides; and d) 29 (29.3%) are transcribed in a decoupled configuration, where the 
autoregulator and target structural genes are in separate operons. These results show that 
a variety of different transcriptional configurations are used in autoregulated gene circuits. 
One immediate question then is whether a given transcriptional configuration endows 
circuits with certain properties not possible in other configurations. If so, then the next 
question is what these properties are. To answer this question, we constructed a simple 
model of a negatively autoregulatory gene circuit and then analyzed the effect of 
arranging the circuit in these different configurations. 
4.2.2 Model development 
One of the major differences between a simple autoregulatory circuit arranged in a 
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tandem configuration versus one arranged in either a divergent or decoupled 
configuration is that the expression of the regulatory and structural gene are proportional 
in the case of former but not necessarily in the cases of the latter. Proportional expression 
means that a large change in the expression of the structural gene necessitates an 
equivalently large change in the expression of the regulator. In a tandemly arranged 
circuit, both genes are transcribed from the same promoter and, as a consequence, their 
expression is proportional. However, in a divergent or decoupled configuration, the 
expression of the structural and regulatory genes need not be directly proportional, as the 
genes are transcribed from different promoters. In this case, a large change in the 
expression of the structural gene does not necessarily imply a large change in the 
expression of the regulator. Thus, some gene circuits may potentially employ either a 
divergent or decoupled configuration in order to maximize expression of the structural 
gene while simultaneously minimizing expression of the regulator. 
 
Figure 4.5: The tetRA circuit from transposon Tn10. 
To develop this idea, we employed the tetRA circuit from transposon Tn10 as our basis 
for comparison [17] (Figure 4.5). This circuit confers tetracycline resistance and consists 
of two genes, tetR and tetA, arranged in a divergent configuration [18]. The tetA gene 
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encodes for a tetracycline efflux pump [19]. TetA expression needs to be tightly regulated, 
as high levels of TetA are lethal to the cell [20]. TetR regulates the expression of TetA in 
response to cytosolic tetracycline. In the absence of tetracycline, dimeric TetR binds the 
PR/PA divergent promoter and represses transcription in both directions. When TetR is 
bound with tetracycline, the repressor no longer binds the promoter and inhibits 
expression from the PR/PA promoter, enabling transcription of the tetR and tetA genes to 
proceed in divergent directions [21]. 
The PR/PA divergent promoter actually consists of three overlapping promoters, where the 
PA promoter controls TetA expression and the PR1 and PR2 promoters control TetR 
expression [18,22]. In the absence of tetracycline, the TetR dimer can bind one of two 
operator sites, O1 and O2, and repress transcription from the PA promoter. When 
tetracycline binds and inactivates TetR, the repressor no longer inhibits the PA promoter, 
enabling expression of TetA and clearance of tetracycline from the cell. TetR also 
regulates its own expression in a divergent configuration. Unlike the tetA gene, the tetR 
gene is transcribed from two promoters, PR1 and PR2. The PR1 promoter is repressed when 
either O1 or O2 is bound with TetR. However, the PR2 promoter is repressed only when 
O1 is bound with TetR [23] (Figure 4.6). As we will demonstrate, these differences in 
the regulation are a key element in the regulation of this circuit. 
88 
 
 
Figure 4.6: Mechanisms underlying the regulation of the tetRA circuit. 
To analyze the effect of configuration and differential regulation, we constructed a simple 
mathematical model of the tetRA circuit. In constructing this model, we made a number 
of simplifying assumptions: 
1. Transcription and translation are treated as a single step in the model. As a 
consequence, the rate of protein synthesis is assumed to be proportional to the amount of 
mRNA produced. Our rationale is that regulation occurs exclusively at the level of 
transcription. In terms of the model, separately including transcription and translation 
does not alter the results or predictions. 
2. Promoter activity is modeled using equilibrium thermodynamics expressions (i.e. Hill-
type expressions) [24]. Implicit in these expressions is the application of the quasi steady-
state assumption. In particular, we assume that the binding and unbinding of TetR to the 
operator sites are fast (relative to the other reactions) and that these reactions effectively 
89 
 
operate at steady state.  
3. The model assumes that the binding of tetracycline to TetR is an irreversible process.  
Our justification is that TetR has a very high affinity for numerous tetracycline analogs 
(KA=10
9
-10
12
M
-1
). Due to these high affinities, the rate of disassociation is very slow. In 
the case of anhydrotetracycline (aTc), the tetracycline analog used in this study, the half-
life of the TetR-aTc complex is approximately thirty-eight hours, far longer than the time 
scale of the cell cycle and our experiments. Our arguments here are derived from the 
work of Nevozhay and coworkers, who previously modeled a synthetic autoregulatory 
circuit in yeast utilizing TetR [5].  
4. The model does not account for the effect of tetracycline efflux due to the action of 
TetA or any other transport system. While the dynamics of TetA efflux are clearly 
important, our experiments did not involve TetA but instead a fluorescent reporter gene. 
We note that secondary efflux systems exist that also may affect gene expression (see 
[25]). However, for simplicity and lack of data, we did not include them in our analysis. 
Likewise, the model does not distinguish between intracellular and extracellular 
tetracycline concentrations even though the two may not be the same due to slow transfer 
rates [26]. 
5. Finally, the model ignores potential transcriptional coupling between the PA and PR 
promoters. While coupling has not been explicitly quantified to the best of our knowledge 
in the case of the PR/PA divergent promoter, it likely occurs.  
Based on the assumptions enumerated above, we can model the tetRA circuit using the 
following three differential equations: 
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where  denotes the concentration of TetA, R  the concentration of free TetR, and  
the concentration of tetracycline-bound TetR, and  the concentration of tetracycline. 
The parameter definitions are given in Table 4.1.  
Table 4.1: Model variables and parameters. 
Name Description Units 
t  Time s 
A  TetA Concentration M 
R  TetR Concentration (free) M 
TR  TetR Concentration (bound) M 
L  Tetracycline Concentration M 
Ak  PA promoter expression rate M s
-1 
1Rk  PR1 promoter expression rate M s
-1
 
2Rk  PR2 promoter expression rate M s
-1
 
1K  Equilibrium binding constant for O1 M
-1
 
2K  Equilibrium binding constant for O2 M
-1
 
Ad  TetA degradation/dilution s
-1
 
Rd  TetR degradation/dilution s
-1
 
Lk  Tetracycline association rate constant M
-1 
s
-1 
 
A TR
L
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Briefly, the first term to the right of the equality sign in Equation (1) describes the rate of 
TetA ( ) synthesis as a function of the concentration of unbound TetR (R ). Both the O1 
and O2 operator sites need to be free in order for the PA promoter to be active. As 
cooperative interactions between these two sites are not believed to occur, we modeled 
binding to these two operator sites as independent events (denoted by the product of the 
two quantities in parentheses). The second term in Equation (1) describes the aggregate 
rate of TetA degradation and dilution due to cell growth. Likewise, the first two terms in 
Equation (2) describe expression from the PR1 and PR2 promoters, respectively. Both the 
O1 and O2 operator sites need to be free in order for the PR1 promoter to be active 
whereas only the O1 operator site needs to be free for the PR2 promoter to be active. The 
third term describes the aggregate rate of unbound TetR degradation and dilution due to 
cell growth. The fourth describes the binding of tetracycline to TetR. Similarly, the first 
term to the right of equality in Equation (3) is used to denote tetracycline binding and the 
second degradation and dilution. 
When the PR2 promoter is inactive ( ), the tetA and tetR genes are regulated in 
identical manner. In terms of the model, an equivalent scenario arises when both gene are 
expressed from the PA promoter in a tandem configuration, where difference in 
expression would arise solely from differences in translational efficiency. Therefore, we 
can use the same model to explore differences between a divergent and tandem 
configuration. However, the model is unable to distinguish between a divergent and 
decoupled configuration, and the two are treated as equivalent in our subsequent analysis 
(designated in the remainder as a divergent/decoupled configuration). As noted in our 
fifth assumption, we did not explicitly include transcriptional coupling in the model, 
A
2 0Rk 
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presumably the aspect that distinguishes a single divergent promoter from two decoupled 
promoters. 
4.2.3 Computational analysis 
Using the model, we compared the behavior of the tetRA circuit in the tandem and 
divergent/decoupled configurations. To remove the dependency on the absolute 
parameter values, we recast the model in dimensionless form (see Materials and Methods) 
and investigated steady-state expression in the absence and presence of saturating 
tetracycline concentrations. Specifically, we fixed TetA expression capacity and then 
determined what the associated expression capacity for TetR was as a function of the free 
parameters:  , the relative binding affinity of TetR for the two operator sites, and  , the 
ratio of 2Rk  to 1 2R Rk k . The expression capacity is defined as the ratio of TetA or TetR 
expression under saturating inducing (L   ) and non-inducing ( 0L  ) conditions [12]. 
By fixing the TetA expression capacity, we were able to eliminate the remaining free 
parameters in the model (see Materials and Methods for details). We also introduced an 
additional variable that we called the control cost, defined as the ratio of the TetR and 
TetA expression capacities. This variable describes how large the change in TetR 
expression needs to be relative to the change in TetA expression. When the value is low, 
a large change in TetA expression does not require an equivalently large change in TetR 
expression. 
Solving the model as a function of the TetA expression capacity, we found that the 
divergent/decoupled configuration had a lower control cost than the tandem configuration, 
which has a control cost of one for all TetA expression capacities (Figure 4.7).  
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Figure 4.7: Control cost as a function of the TetA expression capacity . 
The expression capacity is defined as the ratio of TetA or TetR expression under inducing 
and non-inducing conditions. Control cost is defined as the ratio of the expression 
capacity (TetR( L   ) / TetR( 0L  )) / (TetA( L   ) / TetA( 0L  )). In order to 
facilitate comparison, TetA expression under inducing conditions was fixed at one. Note 
that control cost is one for all TetA expression capacities for a circuit arranged in a 
tandem configuration. 
Furthermore, this difference increases as the expression capacity for TetA increases. 
When we broke the control cost into its individual terms, there was no significant 
difference in TetR expression in the absence of the tetracycline inducer; rather, the 
difference was due to the expression in saturating inducer concentrations (Figure 4.8). 
Collectively, these results demonstrate that the divergent/decoupled configuration 
minimizes the amount of TetR necessary to regulate the circuit relative to the tandem 
configuration. 
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Figure 4.8: TetR expression as a function of the TetA expression capacities.  
Note that TetR expression in the absence of inducer (dashed line) is identical in the 
divergent/decoupled and tandem configurations. Simulations were performed with 1  , 
0.8   (divergent/decoupled), and 0   (tandem). These values best fit our 
experimental measurements. 
We next explored how the model predictions were affected by the two free parameters: 
  and  .  
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Figure 4.9: Modeling results for different values of  , the ratio of the O2/O1 
disassociation constants. 
 In these simulations, 0.8  . 
In the case of  , large values for this parameter mean that, in the absence of inducer, the 
PR2 promoter is more active than the PR1 and PA promoters as it is less strongly repressed 
by TetR (due to it lacking the higher-affinity O2 operator site). As the simulation results 
show, however, this parameter has only a marginal effect on the control cost (Figure 4.9).  
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Figure 4.10: Modeling results for different values of  , the ratio of 2R
k
 to 
1 2R Rk k . 
Note that when   0 , the divergent/decoupled and tandem configurations are equivalent. 
In these simulations, 3  .  
In the case of  , the value of this parameter determines the relative contribution of the 
PR2 promoter to TetR expression and the extent of differential regulation of the two genes. 
Simulations demonstrate that increasing the value of this parameter significantly 
decreases the control cost (Figure 4.10). The reason is that as the parameter   
approaches one, expression of TetA and TetR becomes increasingly uncorrelated because 
the PR2 promoter becomes dominant. Conversely, when   0 , expression is perfectly 
correlated as the two genes are identically regulated (equivalent to circuit being arranged 
in a tandem configuration).  
Finally, we explored the consequence of control cost. In particular, we determined 
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whether high levels of TetR expression would affect circuit behavior. As shown in 
Figure 4.11, we found that the sensitivity of the circuit to inducer in the 
decoupled/divergent configuration is greater than an otherwise equivalent circuit in a 
tandem configuration. The reason is that as more TetR is produced, more tetracycline 
inducer is required to titrate all of the repressor in order to activate the circuit.  
 
Figure 4.11: Comparison of dose-response behavior for divergent/decoupled 
and tandem configuration. 
The TetA expression capacity was fixed at value of 100 in this simulation. Simulations 
were performed with 1  , 0.8   (divergent/decoupled), and 0   (tandem). 
Consistent with this mechanism, we found that increasing the TetA expression capacity 
reduces the sensitivity to inducer, both for the divergent/decoupled and tandem 
configurations (Figure 4.12). As the TetA expression capacity increases, more repressor 
is needed regardless of the configuration.  
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Figure 4.12: Effect of different TetA expression capacities on dose-response 
behavior. 
TetA capacity = 50, solid lines; TetA capacity = 250, dashed lines. Simulations were 
performed with 1  , 0.8   (divergent/decoupled), and 0   (tandem). 
Lastly, we explored how sensitivity was affected by the parameter  . As this parameter 
increases from a value of zero to one, transcription between TetR and TetA becomes 
increasingly uncorrelated.  
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Figure 4.13: Results for different values of  .  
Curves vary from 0   (right, gray line) to  1   (left, black line, with equidistant 
values for the intermediate curves.  Simulations were performed with 1   and the TetA 
capacity set to 100. 
As shown in Figure 4.13, the sensitivity increases as the parameter   increases. These 
results are entirely consistent with our previous ones where we show that this change 
reduces TetR expression (Figure 4.9). With regards to the parameter  , we found that it 
had a minimal effect on the sensitivity (results not shown), consistent with what we 
observed with control cost (Figure 4.10). 
4.2.4 Experimental analysis 
In the preceding section, our modeling results demonstrated that negative autoregulatory 
gene circuits arranged in a divergent or decoupled configuration potentially have a 
reduced control cost relative to one arranged in a tandem configuration, in the sense that 
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less regulator is required under saturating concentrations of inducer. The reason is that 
expression of the regulator is decoupled from the expression of the structural gene. In 
addition, we found that when the control cost was reduced the circuit was more sensitive 
to tetracycline, as less inducer is required to titrate all of the regulator proteins in order to 
activate expression. To test these predictions, we built five synthetic constructs based on 
the tetRA circuit arranged in different configurations (Figure 4.14).  
1.  
2.  
3.  
4.  
Figure 4.14 (cont. on next page) 
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5.  
Figure 4.14: Schematic of synthetic designs used to compare divergent, 
decoupled, and tandem configurations. 
In the first construct, we reproduced the tetRA circuit from Tn10 except that we replaced 
the tetA gene with mCherry and fused the Venus yellow fluorescent protein to the C-
terminus of TetR [27,28]. Otherwise, the construct was identical in the sense that the 
upstream regions of the tetR-Venus and mCherry genes were designed so that they 
matched those of the tetR and tetA genes from Tn10. In the second construct, we again 
utilized the PR/PA divergent promoter except that we placed the tetR-Venus gene fusion 
behind the mCherry gene in a tandem configuration where both genes were expressed 
solely from the PA promoter. Again, the upstream region of the mCherry gene matched 
the tetA gene from Tn10. In the third construct, we placed the mCherry and tetR-Venus 
genes behind the TetR-regulated PLtetO-1 promoter in a tandem configuration [29]. This 
construct was included to control for any possible disruptions to the PR/PA divergent 
promoter due to the absence of the tetR gene being expressed from the PR1 and PR2 
promoters. In the fourth construct, we arranged the tetRA circuit in a decoupled 
configuration by using two copies of the PR/PA divergent promoter, one expressing 
mCherry and the other tetR-Venus from their respective promoters. Otherwise, this design 
is identical to the first construct. In the fifth construct, we placed the mCherry and tetR-
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Venus genes behind the PLtetO-1 promoter in a decoupled configuration, where two copies 
of the promoter were used to express each respective gene. This last construct was 
included to test the effect of differential regulation in a decoupled configuration, as both 
genes will be identically regulated when expressed from the PLtetO-1 promoter and 
differentially regulated when expressed from either side of the PR/PA divergent promoter. 
All designs were initially built on plasmids and then integrated single copy into the 
chromosome at the attHK022 attached site for the designs arranged in divergent and tandem 
configurations and the attHK022 and attΦ80 phage attachment sites for the designs arranged 
in a decoupled configuration [30]. Schematics of the PR/PA and PLtetO-1 promoters are 
given in Figure 4.15.  
 
Figure 4.15: Schematics of the PR/PA and PLtetO-1 promoters. 
To compare the response of these five constructs, we separately induced cells harboring 
each design for six hours at varying concentrations of the tetracycline analogue, 
anhydrotetracycline (aTc), and then measured fluorescence in order to determine relative 
levels of TetR-Venus and mCherry expression (Figure 4.16). In these experiments, we 
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found that much less TetR-Venus was expressed in the divergent and decoupled 
configurations utilizing the PR/PA promoter than in the other configurations where the 
transcription of the two genes is proportional (i.e. coupled configurations). Despite 
reduced TetR-Venus expression, mCherry was expressed at similar magnitudes in all five 
designs, with expression greatest in the decoupled configuration involving the PLtetO-1 
promoter and least in the tandem configuration involving the PR/PA promoter.  
A.  
Figure 4.16 (cont. on next page) 
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B.  
Figure 4.16: Comparison of gene expression in five circuit designs as a 
function of the  aTc inducer. 
A. Expression from the PA promoter as determined by mCherry fluorescence; B. 
Expression from the PR1/PR2 promoter as determined by TetR-Venus fluorescence. 
Legend: circles, divergent configuration (design 1); x-marks, tandem configuration 
utilizing the PR/PA promoter (design 2); diamonds, tandem configuration utilizing the 
PLtetO-1 promoter (design 3); squares, decoupled configuration utilizing the PR/PA 
promoter (design 4); and triangles, decoupled configuration utilizing the PLtetO-1 promoter 
(design 5). Gray lines denote associated model fit. Individual plots are given in Figures 
18-22. At concentrations higher than 430 nM of aTc, cell growth began to be inhibited; 
no decrease in cell viability as determined by the growth rate was observed for 
concentrations less than 430 nM. 
When cast in terms of control cost (Figure 4.17), we found that these experimental 
results were consistent with the general predictions of the model. In particular, the 
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divergent and decoupled configurations utilizing the PR/PA promoter have a much lower 
control cost than the other designs. Note that both TetR-Venus and mCherry are 
equivalently regulated in the decoupled configuration involving the PLtetO-1 promoter, so 
the relatively high level of TetR-Venus expression is entirely expected based on our 
analysis (equivalent to 0   in Figure 4.10). While the general results from the model 
hold, we found that the actual control cost is much greater in the coupled configurations 
than would be predicted by the model. In particular, the model predicts that the control 
cost is one when the expression of regulator and structural gene are identically controlled. 
However, we observed significantly larger values experimentally, particularly in the case 
of the tandem configuration utilizing the PR/PA promoter and the decoupled configuration 
utilizing the PLtetO-1 promoter. The mismatch between the model and experiments here is 
not due, we believe, to any defect in the model; rather it is due to our inability to 
accurately measure low levels of gene expression using the fluorescent reporters. When 
we consider the entire range of inducer concentrations, however, we observed much 
better match between the model and data (see below).  
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Figure 4.17: Experimental determination of control cost for the five designs. 
The control cost is defined as the ratio of the TetR-Venus and mCherry expression 
capacities. The capacities for the respective reporter was determined by taking the ratio of 
normalized fluorescence reading (RFU/OD) under saturating inducing (430 nM of aTc) 
and non-inducing conditions for TetR-Venus and mCherry, respectively.  
In addition to control cost, we observed that circuits arranged in the divergent and 
decoupled configurations involving the PR/PA promoter were more sensitive to the aTc 
inducer than the ones in the coupled configurations, in close agreement with the model 
predictions (Figure 4.16). Again, as these circuits require less regulator, less inducer is 
required to titrate them.  
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Table 4.2: Comparison of divergent and tandem configurations using 
plasmid-based designs as opposed to chromosomally integrated on.  
The values in the Table were obtained by fitting the data to the Hill equation 
 max min min
N
N N
L
F F F F
K L
  

, 
where L  denotes the concentration of aTc. 
Plasmid-Based Design 
 TetR-Venus Expression 
(RFU/OD) 
     mCherry Expression 
(RFU/OD) 
 Divergent Tandem Tandem 
PL 
Divergent Tandem Tandem 
PL 
Fmax 17613.6 38843.0 56816.7 28056.0 4,915.9 15824.3 
Fmin 1890.5 1271.1 1736.7 673.3 172.0 377.8 
KM 134.9 257.8 350.6 145.5 227.4 333.0 
N 3.1 2.0 1.9 3.5 2.3 2.2 
 
Chromosomally-Integrated Design 
 TetR-Venus Expression 
(RFU/OD) 
     mCherry Expression 
(RFU/OD) 
 Divergent Tandem Tandem 
PL 
Divergent Tandem Tandem 
PL 
Fmax 199.1 2767.0 3093.4 512.6 340.0 599.9 
Fmin 81.9 170.8 198.8 52.6 48.5 59.1 
KM 1.1 22.6 21.1 1.3 18.8 18.1 
N 1.4 1.6 1.8 1.4 1.3 1.7 
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As a further test of this result, we compared the divergent and tandem configurations 
involving the PR/PA promoter on medium-copy plasmids (ColE1 origin of replication). In 
these designs, we did not observe a significant difference in sensitivity, roughly two-fold 
in the case of the plasmids as opposed to ten-fold when integrated (Table 4.2). We 
suspect that the increased gene dosage associated with multiple plasmid copies 
counteracts the decrease in expressed regulator associated with the divergent 
configuration. 
Table 4.3: Parameter estimates for model. 
 Design 
Parameter 1 2 3 4 5 
A Ak d  1.8×10
3 
1.0×10
3 
1.4×10
3
 1.2×10
3
 2.6×10
3
 
1R Rk d  0.5×10
2
 4.6×10
3
 4.6×10
3
 0.3×10
2
 5.5×10
3
 
2R Rk d  2.2×10
2
 0 0 1.2×10
2
 0 
 
As a final test, we fit the model to the dose-response data for the five designs in order to 
evaluate the consistency of the model with experimental data (Figures 4.16 and 4.18-
4.22). The associated parameters are given in Table 4.3. In fitting the model to the data, 
we fixed the common parameters ( 1K , 2K , and LK ) and only varied those specific to a 
given design ( A Ak d , 1R Rk d , and 2R Rk d ). As we considered only the steady-state 
response, we were unable to estimate unique values for the parameters Ak , 1Rk , 2Rk , Ad  
and Rd . Rather, we could only estimate their quotients. Note that values of the design-
specific parameters ( A Ak d , 1R Rk d , and 2R Rk d ) are simply determined by the 
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average fluorescence values observed under saturating concentrations of aTc (200-400 
nM). With regards to the parameters 
1R Rk d , and 2R Rk d , we assumed that PR2 
promoter was four times stronger than the PR1 promoter based in part on previous 
measurements [31]. In addition, we set 
2R Rk d  equal to zero for the designs utilizing a 
tandem configuration and the ones utilizing the PLtetO-1 promoter. With regards to the 
common parameters 
1K  and 2K , we set 1 2K K  for the design utilizing the PLtetO-1 
promoter as it harbors two identical O1 operator sites. Finally, to fit the model to the data, 
we needed to convert the normalized fluorescence values to TetR protein concentrations.  
Overall, we found that the model was able to fit the experimental data well for all 
configurations (Figure 4.18-4.22). These results, collectively, provide experimental 
support for our theoretical predictions regarding how the physical encoding of an 
autoregulatory gene circuit can affect its behavior. Our experimental results support the 
general conclusions of our analysis concerning control cost and sensitivity to inducer. In 
particular, we were able to show that our simplified model of the tetRA circuit was able to 
describe the response for all five designs investigated experimentally.  
 
 
110 
 
 
 
Figure 4.18: Model fit for divergent configuration (design 1). 
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Figure 4.19: Model fit for tandem configuration utilizing the PR/PA 
promoter (design 2). 
 
112 
 
 
 
Figure 4.20: Model fit for tandem configuration utilizing the PLtetO-1 
promoter (design 3). 
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Figure 4.21: Model fit for decoupled configuration utilizing the PR/PA 
promoter (design 4). 
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Figure 4.22: Model fit for decoupled configuration utilizing the PLtetO-1 
promoter (design 5). 
4.3 Discussions 
In this work, we investigated how the physical encoding and differential regulation of a 
gene circuit can potentially affect its behavior. Using the tetRA gene circuit from 
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transposon Tn10 as our basis, we compared the behavior of a negatively autoregulated 
gene circuit arranged in either a divergent, decoupled, or tandem configuration. 
Mathematical modeling predicted that the divergent and decoupled configurations 
potentially afforded more flexibility relative to the tandem configuration with regard to 
the amount of regulator needed to fix the expression capacity of the circuit. The basic 
rationale is as follows. In a tandem configuration, TetA and TetR expression is 
proportional, as both proteins are translated from the same mRNA transcript. Therefore, a 
large change in TetA expression, associated with a high expression capacity, necessitates 
an equivalently large change in TetR expression. In the divergent and decoupled 
configurations, on the other hand, TetA and TetR expression need not be proportional, as 
the two sets of promoters can be differentially regulated. In this case, a large change in 
TetA expression does not necessarily imply a large change in TetR expression. Thus, by 
avoiding the proportional expression associated with the tandem configuration, the tetRA 
gene circuit may employ a divergent configuration in order to maximize the TetA 
expression capacity while simultaneously minimizing TetR expression. Moreover, we 
found that high levels of TetR expression require high concentrations of tetracycline to 
activate the circuit, as more inducer is required to titrate all of the repressor molecules. 
These results provide one possible role for the divergent promoter in the tetRA circuit. 
To test these theoretical predictions, we constructed five synthetic gene circuits in order 
to compare the tandem, decoupled, and divergent configurations. Three utilized the PR/PA 
divergent promoter from the tetRA circuit where the TetR-Venus regulator and mCherry 
reporter genes were arranged either in a divergent, decoupled, or tandem configuration. 
The other two utilized the PLtetO-1 promoter where the two genes were arranged either in a 
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decoupled or tandem configuration. These designs were included to test for the affect of 
differential regulation in the case of the decoupled configuration and to account for any 
biases associated with employing the PR/PA promoter in the case of the tandem 
configuration.  By measuring the response of these five circuits at varying levels of the 
inducer anhydrotetracycline (aTc), we found that the divergent and decoupled 
configurations utilizing the PR/PA promoter expressed less TetR than the others both in 
absolute and relative terms, thus validating the main prediction of our model. Likewise, 
we also found that these circuits were more sensitive to the inducer aTc, again in 
agreement with the model. In other words, these circuits were activated at lower 
concentrations of aTc than the ones in the other configurations. Collectively, these results 
provide one example of how the physical arranged and differential regulation of a gene 
circuit can potentially affect its behavior.  
In terms of physiological significance, the reason that the tetRA circuit in Tn10 is 
arranged in a divergent configuration most likely relates to its role in antibiotic resistance. 
The reduction in control cost afforded by this transcriptional configuration makes the 
tetRA circuit more sensitivity to tetracycline and thus offers one potential evolutionary 
advantage for this design. As a corroborating example, the antibiotic resistance circuit 
regulating the expression of the AcrAB efflux pump in E. coli is also arranged in a 
divergent configuration [32]. However, other designs offer similar advantages. For 
example, if the TetR regulator is constitutively expressed at low levels, then this design 
would also increase the sensitivity to tetracycline. However, the resulting design would 
be less robust as the lack of feedback would mean that TetA expression may not be as 
tightly regulated. This is particularly relevant when the unwarranted expression of the 
117 
 
structural genes is potentially detrimental to cell viability, as is the case with the TetA 
efflux pump [20]. Even in presence of feedback, other design could be equally optimal 
with regards to control cost and sensitivity. In fact, based on the assumptions used to 
develop our model, we were unable to distinguish between the divergent and decoupled 
configurations. This would suggest that the divergent configuration offers additional 
regulatory advantages. One likely candidate is transcriptional coupling.  
A transcribing RNA polymerase can generate positively supercoiled domains in front of 
it and negatively supercoiled domains behind it [33,34]. In a divergent promoter, a newly 
transcribing RNA polymerase elongating in one direction can affect transcription in both 
directions due to formation of negatively supercoiled domains in the promoter region. 
Negative supercoiling can enhance the activity of the promoter in both directions, 
presumably by reducing the free energy for open complex formation or by favorably 
altering local DNA topology [35,36]. The net effect is that transcription in one direction 
enhances it in the other direction, thus coupling transcription from both sides of the 
promoter. The ilvYC operon in E. coli is one example where coupling in divergent 
promoters due to negative supercoiling is known to occur [37].  
In addition to supercoiling, the close proximity of the binding sites for RNA polymerase 
couples transcription on both sides of the promoter through steric interactions. Such 
interactions may affect transcription in one or both directions. In the case of the lambda 
PR/PRM promoter, the competitive binding of CI, Cro, and RNA polymerase to their 
respective sites within this control region can facilitate the selective activation of one 
promoter and repression of the other. Another example is the closely spaced PR/PRM 
promoter from bacteriophage 434, where the binding of RNA polymerase in one 
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orientation physically prevents the binding of a second polymerase in the opposite 
orientation [38]. The result is that transcription can proceed in only one direction at a 
given time. The close proximity of the promoters also means that the same transcription 
factor can regulate the activity of both. The binding of the regulator to operator sites 
within the divergent promoters can either activate/inhibit the transcription in both 
directions or activate transcription in one direction and repress it in the opposite direction 
[39].  
In this work, we did not explore the effect of transcriptional coupling due to negative 
supercoiling and steric interactions. To include these effects in our theoretical analysis, 
we would need to employ higher resolution models that explicitly account for interactions 
between RNA polymerase and the repressor along with their effect on local DNA 
topology. Despite the limited resolution of our model, however, we cannot imagine how 
transcriptional coupling would affect the predictions regarding control cost and 
sensitivity. That said, transcriptional coupling may play an important role with regards to 
robustness. In particular, by directly linking the transcription of the regulator to that of 
the structural genes, the strength of repression is ensured to be proportional to the output 
response. This additional feedback may be important, for example, in preventing “leaky” 
expression of structural genes in the absence of inducer. A tandem configuration, 
however, also provides the same degree of coupling, though the associated control cost is 
high when we also consider expression in the presence of inducer. Transcriptional 
coupling, on the other hand, may provide the divergent configuration with the advantages 
of coupling at low levels of expression without incurring the cost associated with high 
levels of expression. For this to be true, effect of transcriptional coupling would need to 
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be most pronounced when expression is low and have only a marginal effect when 
expression high. While speculative and still unsubstantiated, this hypothesis provides one 
possible explanation for the differences between the divergent and decoupled 
configurations.   
One question that we have not been able to answer in our analysis is why are some 
circuits are arranged in tandem configurations, a configuration that we argue is 
suboptimal with respect to control cost. In particular, roughly a quarter of all 
autoregulatory gene circuits in E. coli are arranged in a tandem configuration (Figure 
4.4). Even in the case of antibiotic resistance circuits, the tandem configuration is 
observed. For example, the antibiotic resistance circuit regulating the expression of the 
EmrAB efflux pump in E. coli is arranged in a tandem configuration [32]. These results 
suggest that control cost is not the sole factor in the evolutionary design equation and that 
others are equally, if not more important. Clearly, further work is needed to better resolve 
these design principles, though we note that a number of other mathematical theories 
have been developed to predict the optimal mode of coupling and regulation in different 
gene circuits, most notably by Savageau and coworkers (cf. [12]). The significance of this 
work is that we provided one specific example of how different physical encodings of a 
gene circuit can influence its behavior. 
Finally, we note that autoregulated gene circuits involving positive regulation are also 
analogously arranged in different configurations. Though not explicitly addressed in this 
work, the conclusions regarding control cost apply to those involving positive regulation. 
In particular, the divergent and decoupled configurations enable the regulator and 
structural genes to be differentially regulated, and the mode of regulation does not affect 
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this result. However, the associated results regarding sensitivity likely do not translate as 
only a single ligand-bound regulator is necessary to activate transcription when positive 
regulation is involved. Where the issue gets murky with regards to sensitivity is when one 
considers dual-mode regulators such as AraC that function both as repressor and activator 
[40].  
In summary, we have quantified how the transcriptional organization of a negatively 
autoregulated gene circuit can potentially affect its behavior. In particular, we have 
shown that certain configurations allow for the differential regulation of the regulator and 
structural genes whereas others do not. The significance of this work is that it has 
uncovered a new facet to regulation. Likely, as more complex configurations and circuits 
are considered, many new principles will emerge. Collectively, these results reveal an 
extra degree of complexity to the analysis of gene circuit by demonstrating how the 
physical encoding of the circuit can play a role in determining its behavior. 
4.4 Materials and methods 
4.4.1 Media and growth conditions 
All experiments were performed in Luria-Bertani (LB) media at 37°C except for those 
involving the helper plasmid. Those involving growth of cells carrying the helper plasmid 
were performed at 30˚C as described previously [30]. Loss of the helper plasmid was 
achieved by growth at 42˚C.  
4.4.2 Plasmid construction 
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Tables 4.4 and 4.5 provide a list of all plasmids and oligonucleotides used in this study. 
Basic cloning steps were performed in E. coli strain DH5α. Cloning steps involving 
CRIM plasmids (R6K origin) were performed in the pir
+
E. coli strain BW25141 
(lacI
q
rrnB3 ΔlacZ4787 hsdR514 DE(araBAD)567 DE(rhaBAD)568 ΔphoBR580 rph-1 
galU95 ΔendA9 uidA(ΔMluI)::pir(wt) recA1) [30]. All enzymes were obtained from New 
England Biolabs or Stratagene and used according to the manufacturer‟s 
recommendations. Primers were purchased from IDT Inc. 
The tetR gene was amplified by PCR using transposon Tn10 as the template with primers 
KW012F and KW012R harboring NotI and AseI restriction sites. The fragment was 
inserted into the plasmid pPROTet.E (Clontech) using these restrict sites resulting in the 
plasmid pKW005. The TetR-Venus fusion protein was constructed using the linker 
GENLYFQSGGA [4]. Two rounds of PCR were used to construct the fusion protein. In 
the first round of PCR, the tetR and Venus genes were amplified with complementary 
ends using the primers CR002F and KW121R for tetR and the primers KW121F and 
KW011R for Venus. In the second round of PCR, the fragments from the first round were 
amplified and fused using primers CR002F and KW011R and then cloned into the EcoRI 
and BamHI restriction sites of pPROTet.E, resulting in the plasmid pKW574.  
Table 4.4: Plasmids used in this work. 
Plasmids Genotype Reference 
pAH69 Helper plasmid for integration at attHK022, Amp
R
 [30] 
pAH123 Helper plasmid for integration of attΦ80, Amp
R
 [30] 
pKW005 pPROTet.E derivative harboring tetR, Cm
R
 This work 
pKW025 pPROTet.E derivative, PR/PA promoter, Cm
R
 This work 
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pKW574 pPROTet.E derivative harboring tetR-venus, Cm
R
 This work 
pKW602 pPROTet.E derivative, T2-PR/PA, Cm
R
 This work 
pKW604 pKW602 derivative, PR/PA-mCherry, Cm
R
 This work 
pKW610 pKW602 derivative, (tetR-venus)-PR/PA-mCherry, Cm
R
 This work 
pKW616 pKW602 derivative, PR/PA-mCherry-(tetR-venus), Cm
R
 This work 
pKW656 
pPROTet.E derivative, PR/PA -mCherry-(tetR-venus), 
Cm
R
 This work 
pKW661 
pLC143 derivative, T2-(tetR-venus)-PR/PA-mCherry-T1, 
Km
R
 This work 
pKW662 
pLC143 derivative, T2-PR/PA-mCherry-(tetR-venus)-T1, 
Km
R
 This work 
pKW663 pKW602 derivative, (tetR-venus)-PR/PA, Cm
R
 This work 
pKW664 pLC143 derivative, T2-(tetR-venus)-PR/PA-T1, Km
R
 This work 
pKW665 pLC153 derivative, T2-PR/PA-mCherry-T1, Cm
R
 This work 
pKW666 pPROTet.E derivative, PLteto-1-(tetR-venus), Cm
R
 This work 
pKW667 pPROTet.E derivative, PLteto-1-mCherry, Cm
R
 This work 
pKW668 pLC143 derivative, PLtetO-1-(tetR-venus)-T1, Km
R
 This work 
pKW669 pLC153 derivative, PLtetO-1-mCherry-T1, Cm
R
 This work 
pKW689 
pLC143 derivative, PLtetO-1-mCherry-(tetR-venus)-T1, 
Km
R
 This work 
pLC143 Integration vector, R6K ori,attHK022, Km
R
 Chubiz 
pLC153 Integration vector, R6K ori,attΦ80, Cm
R
 Chubiz 
pPROTet.E Cloning vector, ColE1 ori, PLteto-1 promoter, Cm
R
 Clontech 
pSE380 pUCori, PTrc promoter, lacI
q
, Amp
R
 Invitrogen 
 
Table 4.5: Oligonucleotides used in this work. 
Primers Sequence (5’→3’) 
CR002F 
ACCATGGAATTCAAGGAGATAGAAATGATGTCTAGATTAGAT
AA 
Table 4.4 (cont.) 
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KW011R ACCAGGATCCTTATTTGTATAGTTCATCCATG 
KW012F 
ACCAGCGGCCGCAAGGAGATAGAAATGATGTCTAGATTAGAT
AA 
KW012R ATCATTAATTTAAGACCCACTTTCAGATT 
KW032F 
TTTTACCACTCCCTATCAGTGATAGAGAGAATTCATTAAAGA
GGAGA 
KW032R 
TAACTCTATCAATGATAGAGTGTCAACACTCGAGGTGAAGAC
GAAA 
KW085R AATAAGCGGCCGCTTACTTGTACAGCTCGTCCAT 
KW121R 
GCCGCTCTGAAAATACAGGTTTTCGCCAGACCCACTTTCACAT
TTAAG 
KW121F 
CTGTATTTTCAGAGCGGCGGCGCGATGAGTAAAGGAGAAGA
AC 
KW135R ATAGCGGCCGCTTATTTGTATAGTTCATCC 
KW165F 
ATACGTCTCCAACAAAAATTAGGAATTAATGATGTCTAGATT
AGATAA 
KW213F ATTCTCGAGAAAATTGGAGCGGATTTGAACGTTG 
KW213R ATTGACGTCAAAAGGCCATCCGTCAGG 
KW214F 
ATTAAAGGTCTCAGAGAAAAGTGAAATGGTGAGCAAGGGCG
AG 
KW214R ATTGGTCTCCTTGTCTTACTACTTGTACAGCTCGTCCAT 
KW215F ATTGGTCTCGACAAGGTGGTCGACAAGCTT 
KW215R ATTGGTCTCTTCTCTATCACTGATAGGGAGTGGT 
KW216R2 ATTCGTCTCCTCGAGTTATTATTTGTATAGTTCATCCAT 
KW217F ATTGGTCTCTTGTTGACACTCTATCATTGAT 
KW217R2 ATTGGTCTCCTCGAGAAAATTGGAGCG 
KW218F 
ATTGGATCCAAAAATTAGGAATTAATGATGTCTAGATTAGAT
AAAAG 
KW219F2 ATTGCATGCAAAAGGCCATCCGTCAGGATG 
KW219R ATTGGTACCTCTAGGGCGGCGGATTTGTCC 
KW234F 
ATAGAATTCAACTAAAGATTAACTTTATAAGAGAAAAGTGAA
ATGGTGAG 
KW244F TCGATGCGGCCGCTTAATTAATT 
Table 4.5 (cont.) 
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KW244R ATAGCGGCCGCACTTTTCTCTATCACTGATAG 
KW245F 
ATAGAATTCAGATTAACTTTATAAAAAATTAGGAATTAATGA
TGTCT 
KW246F ATTGCATGCTCCCTATCAGTGATAGAGATTG 
 
The plasmid pKW602, a derivative of pPROTet.E where the native PLtetO-1 promoter [29] 
was replaced with the PR/PA divergent promoter from Tn10 and flanked by transcriptional 
terminators on both sides, was used in all subsequent cloning unless noted otherwise. 
This plasmid was made in two steps. First, the PLtetO-1 promoter was replaced with the 
PR/PA promoter by amplifying the plasmid without the native PLtetO-1 promoter using 
primers KW032F and KW032R and then re-circularized using blunt-end ligation. The 
new vector was named pKW025. Second, the T2 terminator from pSE380 (Invitrogen) 
was amplified with primers KW213F and KW213R bearing overhanging XhoI and AatII 
restriction sites and then inserted into pKW025. The resulting plasmid was named 
pKW602. 
The plasmid pKW604, a derivative of pKW602, has mCherry under the control of the PA 
promoter. The plasmid was constructed so that the upstream sequence of the mCherry 
gene is exactly the same as the tetA gene from Tn10. The mCherry gene was amplified 
with primers KW214F and KW214R having overhanging BsaI restriction sites. The 
plasmid pKW602 was amplified with primers KW215F and KW215R having 
overhanging BsaI restriction sites. The resulting PCR products were digested with BsaI 
and ligated together to obtain the plasmid pKW604. 
Table 4.5 (cont.) 
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The plasmid pKW610, which encodes the circuit in the divergent configuration, was 
made by amplifying the plasmid KW604 and the tetR-Venus gene from pKW574 and 
then ligating them together after digestion with and BsaI and BsmBI, respectively. Note 
that the upstream sequence of tetR-Venus is the same as the tetR gene in Tn10. The 
plasmid pKW604 was amplified using the primers KW217F and KW217R2. The tetR-
Venus gene was amplified using the primers KW165F and KW216R2.  
The plasmid pKW616, which encodes the circuit in the tandem configuration, was 
obtained by amplifying tetR-Venus with overhanging BamHI and NotI restriction sites 
using the primers KW218F and KW135R. The result PCR product was then cloned into 
pKW604, yielding the plasmid pKW616. 
The plasmid pKW656, which encodes the circuit in the tandem PLtetO-1 configuration, was 
made by first amplifying the mCherry and tetR-Venus fragment from pKW616 using 
primers KW234F and KW135R having overhanging EcoRI and NotI restrictions sites. 
The PCR product was then inserted in the corresponding restriction sites of the plasmid 
pPROTet.E.  
The plasmid pKW663, which encodes for TetR-Venus part of the circuit in the decoupled 
configuration, was constructed by eliminating the mCherry gene from the plasmid 
pKW610. This was accomplished by amplifying plasmid pKW610 with the primers 
KW244F and KW244R and re-circularizing it after digesting the PCR product with NotI.  
The plasmid pKW666, which encodes the TetR-Venus part of the circuit in the decoupled 
PLtetO-1 configuration, was made by amplifying the tetR-Venus gene with the native TetR 
ribosome binding site using the primers KW245F and KW135R. The PCR product was 
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then inserted into pPROTet.E between EcoRI and NotI restriction sites. Similarly, the 
plasmid pKW667 which encodes the mCherry part of the circuit in the decoupled PLtetO-1 
configuration was constructed by amplifying the mCherry gene with the TetA ribosome 
binding site using the primers KW234F and KW085R. The PCR product was then 
inserted into the EcoRI and NotI sites of pPROTet.E. 
4.4.3 Strain construction 
Two CRIM integration vectors pLC143 and pLC153 were used to integrate all circuits at 
single copy into the chromosome of E. coli K-12. These plasmids were constructed by 
replacing the gentamicin resistance gene on plasmids pAH143 and pAH153 [30] with 
kanamycin and chloramphenicol resistance genes, respectively. 
The fragments between and including the terminators T2 and T1 from plasmids pKW610, 
pKW616, pKW656, and pKW663 were amplified using primers KW219F2 and KW219R 
with overhanging SphI and KpnI restriction sites and inserted into pLC143, resulting in 
the plasmids pKW661, pKW662, pKW689, and pKW664. The plasmid pKW665 was 
similarly made by amplifying the fragment between and including terminators T2 and T1 
from pKW604 using primers KW219F2 and KW219R and inserting the fragment into the 
Sph1 and Kpn1 restriction sites of pLC153. Similarly, the fragments between and 
including the PLtetO-1 promoter and terminator T1 on pKW666 and pKW667 were 
amplified using primers KW246F and KW219R and cloned into pLC143 and pLC153 
respectively, resulting in pKW668 and pKW669.  
The divergent circuit involving the PR/PA divergent promoter, strain KW0001, was made 
by integrating the plasmid pKW661 into the attHK022 phage attachment site using the 
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pAH69 helper plasmid as described previously [30]. The tandem circuit involving the PA 
promoter, strain KW0002, was made by integrating the plasmid pKW662 into the attHK022 
phage attachment site. The tandem circuit involving the PLtetO-1 promoter, strain KW0003, 
was made by integrating the plasmid pKW689 into the attHK022 phage attachment site. 
The decoupled circuit involving the PR and PA promoters, strain KW0013, was made by 
integrating pKW664 in the attHK022 phage attachment site and plasmid pKW665 into the 
attΦ80 phage attachment site using the pAH123 helper plasmid [30]. The decoupled 
circuit involving the PLtetO-1 promoter, strain KW0019, was made by integrating the 
plasmid pKW668 into the attHK022 phage attachment site and the plasmid pKW669 into 
the attΦ80 phage attachment site. A list of strains is given in Table 4.6. 
Table 4.6: Strains used in this work. 
Strains Genotype 
KW0001 attHK022::pKW661 (divergent design with PR/PA promoter) 
KW0002 attHK022::pKW662 (tandem design with PR/PA promoter) 
KW0003 attHK022::pKW689 (tandem design with PLtet0-1 promoter.) 
KW0013 
attHK022::pKW664 att Φ80::pKW665 (decouple design with PR/PA 
promoter) 
KW0019 
attHK022::pKW668 attΦ80::pKW669 (decoupled design with PLtetO-1 
promoter) 
 
In the case of the decoupled circuits, we also tested how swapping the phage attachment 
sites affected behavior. As we did not observe any significant differences, we have 
provided these results as supplemental information (Table 4.7). 
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Table 4.7: Results obtained by swapping attachment sites for decoupled 
designs. 
In Case 1, the TetR-Venus component was integrated into the attHK022 phage 
attachment site and the mCherry component was integrated into the attΦ80 phage site. In 
Case 2, the phage attachment sites were swapped. The values in the Table were obtained 
by fitting the data to the Hill equation 
 max min min
N
N N
L
F F F F
K L
  

, 
where L  denotes the concentration of aTc. 
 
TetR-Venus Expression (RFU/OD) 
Decoupled 
(Case 1) 
Decoupled 
(Case 2) 
Decoupled PL 
(Case 2) 
Decoupled PL 
(Case 2) 
Fmax 156.8 286.4 3599.8 3416.1 
Fmin 77.7 93.6 204.9 211.6 
Km (nM) 0.6 1.9 28.2 25.7 
N 0.7 0.4 1.6 1.4 
 
 
mCherry Expression (RFU/OD) 
Decoupled 
(Case 1) 
Decoupled 
(Case 2) 
Decoupled PL 
(Case 1) 
Decoupled PL 
(Case 2) 
Fmax 361.6 411.9 883.4 659.0 
Fmin 27.9 27.3 91.7 66.7 
Km (nM) 2.8 3.2 20.0 17.9 
N 0.4 0.6 1.4 1.2 
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4.4.4 Fluorescence measurements 
To measure fluorescent protein expression, cultures were grown overnight at 37°C in 
non-inducing LB liquid media and then subcultured to an OD600 of 0.05 in fresh LB 
media. After one hour of subculture, cultures were induced by adding aTc and grown for 
6 hours at 37°C. Fluorescence was measured in 96-well plates using a Tecan Safire2 
microplate reader. For Venus expression, the excitation wavelength was set at 515 nm 
and the emission wavelength at 528 nm.  The bandwidth was fixed at 5 nm and the gain 
was set to 100. For mCherry expression, the excitation wavelength was set at 587 nm and 
the emission wavelength at 610 nm.  The bandwidth was fixed at 5 nm and the gain was 
set to 150. Nine readings were taken in each well.  To correct the variation in cell 
numbers, the fluorescence intensity was normalized by the OD600 of the culture. All 
experiments were done in quadruplicate and average values with the standard deviations 
reported.   
4.4.5 Model analysis 
To facilitate analysis and remove the explicit parameter dependence, we recast the model 
in dimensionless form as follows 
 
2 2
1 1
1 1
dA
A
dt R R
  
   
   
 (4) 
 
1 22 2 2
1 1 1
1 1 1
R R R
dR
k k d R L R
dt R R R
    
        
      
 (5) 
 T R T
dR
L R d R
dt
    (6) 
by employing, with convenient abuse of notation, the following variable transformations: 
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and the definition 2 1K K  , where   denotes the relative binding affinity for the two 
operator sites. 
 
If we consider the dimensionless model at steady state in the presence of saturating 
inducer (L   ), then we obtain following solution: 
  1 21, ,
i i
T R R RA R k k d    
where the superscript i  is used to designate that these variables are for the induced case. 
Likewise, in the remainder, the superscript u  is used to designate the uninduced case 
( 0L  ). If we fix the TetA expression capacity ( i uG A A , or equivalently fix uA ), 
then we can determine the associate level of TetR expression in the uninduced case: 
 
   
2
1 1 4 ( 1)
2
u
G
R
  

     
  (7) 
For fixed values of G  and  , equation (7) tells us how much TetR ( uR ) is needed to fix 
TetA expression at the level uA  in the absence of inducer.  Given uR , we can then 
calculate the associated value of i
TR  using the following expression (obtained by solving 
equation (5) using the value for uR ): 
 
 
2
1
u
i
T
u
GR
R
R


 (8) 
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where  2 1 2R R Rk k k   . We can then use this equation to calculate the control cost as 
a function of the free variables G ,  , and   using the following expression: 
 
 
2
1
Control cost 
1 uR


. (9) 
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Chapter 5: Synthetic Overlapping Divergent Promoters 
5.1 Introduction 
Both functional genomics and metabolic engineering requires the fine-tuning of gene 
expression to study the control of the target gene exerted on phenotypes or metabolic 
fluxes of interest. In addition to the traditional methods to vary gene expression like 
knockout [1] or over expression [2] of the target gene, inducible promoters [3,4,5] or 
synthetic promoter libraries [6,7,8,9,10] are used to achieve a wide range of gene 
expression. Inducible promoters often have drawbacks impeding their applications, such 
as, inducer toxicity, cell-cell heterogeneity, and high cost at industrial scales [11,12,13]. 
In contrast, constructing synthetic promoter libraries with varied promoter activities is of 
great interest for fine-tuning gene expression and has been studied by several research 
groups. One commonly used strategy is subjecting a target promoter to error-prone PCR 
and selecting mutants with defined activities [6]. Another strategy is to utilize degenerate 
nucleotides for non-conserved positions when synthesizing the promoter sequence [7,14]. 
The resulted promoter libraries with a wide range of activities can not only provide a 
useful tool for metabolic engineering, also aid in the understanding of the correlation 
between promoter sequence and strength.  
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Figure 5.1: Schematics of an overlapping divergent σ7 promoter. 
Divergent promoters represent a common promoter structure in prokaryotes. 
Approximately 40% of all operons in E. coli are transcribed from divergent promoters 
[15,16], where RNA polymerases binds to closely spaced or overlapping sequence on 
DNA and transcribe their genes in opposite directions along both the positive and 
negative DNA strands. Figure 5.1 illustrates a typical overlapping divergent promoter 
bound by σ70 associated RNA polymerase. A number of hypotheses have been proposed 
to explain the prevalence of divergent promoters in E. coli and other bacteria [17]. The 
most common is that the close proximity of the binding sites for RNA polymerase couple 
transcription on both sides of the promoter, either directly through steric interactions or 
indirectly through alterations in local DNA topology. Such interactions may affect 
transcription in one or both directions. In the case of the lambda PR/PRM promoter, the 
competitive binding of CI, Cro, and RNA polymerase to their respective sites within this 
control region can facilitate the selective activation of one promoter and repression of the 
other. The result is that transcription can proceed in only one direction at a given time. 
Coupling due to indirect interactions can arise from transcription-induced negative 
supercoiling. A transcribing RNA polymerase can generate positively supercoiled 
domains in front of it and negatively supercoiled domains behind it [18,19]. In a 
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divergent promoter, a newly transcribing RNA polymerase elongating in one direction 
can affect transcription in both directions due to formation of negatively supercoiled 
domains in the promoter region. Negative supercoiling can enhance the activity of the 
promoter in both directions, presumably by reducing the free energy for open complex 
formation or by favorably altering local DNA topology [20,21]. The net effect is that 
transcription in one direction enhances it in the other direction, thus coupling 
transcription from both sides of the promoter. The ilvYC operon in E. coli is one example 
of where coupling in divergent promoters due to negative supercoiling is known to occur 
[15].  
In addition to coupling, divergent promoters also enable the same transcription factor to 
regulate the expression of the two operons. The binding of the regulator to operator sites 
within the divergent promoters can either activate/inhibit the transcription in both 
directions or activate transcription in one direction and repress it in the opposite direction 
[17]. This flexibility may be advantageous in autoregulated circuits where the 
transcription factor is on one side of the divergent promoter and the structural genes on 
the other. Clearly, other transcriptional configurations afford some of this flexibility; 
however, the divergent configuration may be unique in facilitating both coupling and 
dual regulation by the same factor. A study comparing the behavior of the tetRA element 
from Tn10 arranged in different promoter configurations, like divergent, tandem 
(unidirectional), or decoupled, showed that divergent promoters allows for differential 
regulation of the  regulator and structural genes afford more flexibility to the circuit and 
less regulator is needed to activate it, thus conferring gene expression more sensitivity to 
the inducer. 
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The ideal aim of promoter engineering is to predict and control gene expression at 
transcriptional level by manipulating the promoter activity through promoter sequence. 
But this is hard to accomplish due to our poor understanding of the correlation between 
sequence and behavior. Experimentations including mutation of certain nucleotides and 
synthetic promoter libraries together with structural studies of RNA polymerase have 
uncovered some features of unidirectional promoters like the one associated with the σ70 
factor. Intrigued by the special structure of divergent promoters, especially overlapping 
promoter, this work intends to create synthetic libraries of overlapping divergent 
promoters. By varying the size of the divergent promoter, we would like to see if 
divergent transcription can be obtained with different promoter size and tuned using a 
minimal sized element. 
5.2 Results 
5.2.1 Testing of the divergent promoter probe 
To test the sensitivity of the divergent promoter probing vector pKW712 designed in this 
work, three synthetic promoters CP25, CP7, and CP4, proposed to show different 
activities in Jensen and Hammer‟s paper [7], were cloned in both directions into pKW712 
and also into a unidirectional promoter probing vector pProbe-GFP [tagless] [22]. In their 
paper, they used β-galactosidase as the reporter for these promoters. As shown in Figure 
5.2, promoters CP25 and CP7 are both hundreds of times stronger than CP4; CP25 is 
about 4 times stronger than CP7.  However, results using pProbe-GFP [tagless] and 
pKW712 both indicated that these three promoters showed roughly the same activity. 
Since inconsistency between β-galactosidase and fluorescent proteins as reporters for 
138 
 
promoter activity is commonly known, this result cannot prove that pKW712 is sensitive 
to work as promoter probes. By contrast, cloning of the synthetic divergent promoters 
designed in this work into pKW712 generated clones with a wide range of fluorescence 
intensity of both Venus and mCherry, which suggests the pKW712 vector series can be 
used as probes for divergent promoters elsewhere. 
 
Figure 5.2: Comparison of activity of CP25, CP4, and CP7 using different 
probing vectors. 
5.2.2 Design and construction of overlapping divergent promoter 
libraries 
The purpose of this work was to construct libraries of synthetic overlapping divergent 
promoters, analyze their sequences, and understand possible sequence features 
influencing the activity of this intriguing promoter arrangement. To generate libraries of 
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synthetic promoters covering a wide range of activities in both orientations, we applied 
the strategy of Jensen and Hammer on synthetic promoter library to our promoter design 
[7]: first, design and synthesize degenerate oligonucleotide sequences that encodes 
overlapping divergent promoters for E. coli with consensus, semi-conserved, and random 
nucleotides as well as restriction sites at both ends; second, synthesize the second strand 
using the Klenow fragment of DNA polymerase I and a short primer complementary to 
the 3‟ non-degenerate end; third, clone the resulting double-stranded DNA fragment 
mixture into a divergent promoter probe vector, in this work, pKW712M. 
 
Figure 5.3: Sequence for a unidirectional promoter.  
Previous study on the sequence of E. coli promoters has identified several conserved 
elements: the Pribnow box or the -10 box TATAAT [23,24], the -35 box TTGACA [25], 
and the extended -10 motif TG [26,27,28,29,30,31]. The optimal space between the -10 
box and -35 box is 17 bp [32]. Another well-conserved sequence is the GTACTGTT 
from +1 to +8 [33]. In addition to these well-known motifs, two semi-conserved base 
pairs were also included: R (A or G) at position -13 and W (A or T) at position -3. Based 
on the information above, an oligonucleotide sequence was formed to represent a 
unidirectional promoter from position -35 to +8 (Figure 5.3).  
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Figure 5.4: Schematics of the three promoter libraries in this work.  
Based on this sequence, we designed three overlapping divergent promoters. As shown in 
Figure 5.4, the two promoters are slightly overlapping in promoter A with their 5‟ end 
next to each other; in promoter B, the two promoters are more overlapping with the -35 
box of one promoter placed in the spacer region between the -35 box and -10 box of the 
other promoter; in promoter C, the two promoters are the most overlapping in all three 
designs with -35 box of one promoter downstream of the -10 box of the other. All three 
overlapping divergent promoters are designed in a way that the conserved and semi-
conserved nucleotides designed for the unidirectional promoter are retained for promoters 
in both direction and nucleotides at other positions are randomized. As a result, promoter 
A has 48 conserved, 4 semi-conserved and 22 random nucleotides; promoter B has 48 
conserved, 4 semi-conserved and 14 random nucleotides; promoter C has 44 conserved, 2 
semi-conserved and 5 random nucleotides. The three promoters all have flanking 
sequencing for recognition sites for restriction enzymes EcoRI and NotI (Figure 5.5).  
141 
 
 
Figure 5.5: Sequences for generating the three promoter libraries.  
The designed oligonucleotide sequences were synthesized by IDT. The mixture of single-
stranded oligonucleotides were converted into double-stranded DNA fragment by the 
Klenow fragment of DNA polymerase I using a short primer complementary to the 3‟-
end non-degenerated flanking sequence. The resulting DNA fragments encoding potential 
overlapping divergent promoters were cloned into the divergent promoter probe vector 
pKW712M (Figure 5.6) and resulted in clones forming three promoter libraries. 
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Figure 5.6: The divergent promoter probing vector pKW712M. 
5.2.3 Activities of the synthetic overlapping divergent promoters 
Around 100 clones were picked from the chloramphenicol plate after transformation and 
screened for mCherry and Venus activities. 52 clones showed positive signals in library 
A, 35 clones in library B, and 69 in library C. The mCherry and Venus activities of these 
clones were measured. The clones with positive signals were sequenced and some of 
them showed a different structure from designed with either a big insertion or deletion. 
After taking these out, library A has 44 members, library B has 30 members, and library 
C has 57 members. Promoters with varied strength in both directions were obtained for 
each library. Using empty plasmid pKW712M as control for background fluorescence, 
library A has overlapping divergent promoters driving Venus expression from 1.6 to 
2628.1 times of the background and mCherry expression from 26.1 to 644.5 times of the 
background. Library B has promoters with Venus expression from 81.8 to 2246.2 times 
of the background and mCherry expression from 79.2 to 886.4 times of the background. 
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Library C has promoters with Venus expression from 0.8 to 1976.3 times of the 
background and mCherry expression from 1.9 to 1163.1 times of the background (Table 
5.1). 
Table 5.1: Summary of the three promoter libraries.  
Name Library A Library B Library C 
Length 74 66 51 
# of Conserved nt 48 48 44 
# of Semi-conserved nt 4 4 2 
# of random nt 22 14 5 
Venus Max 1.6 81.8 120.8 
Venus Min 2628.1 2246.2 1976.3 
Venus Max/Min 1642 27 16 
mCherry Max 26.1 79.2 40.0 
mCherry Min 644.5 886.4 1163.1 
mCherry Max/Min 25 11 29 
 
The selected clones from all three libraries were cultured in M9 minimal media and 
measured the expression of Venus and mCherry kinetically about every 20 min. Venus 
and mCherry expression, normalized to the background using empty plasmid pKW712M 
as control, as well as the time it takes for them to reach the maximum level are plotted in 
Figure 5.7, 5.8, and 5.9. We can see that each library has members with diverse 
expression in both Venus and mCherry. Also, the time they take to get fully expressed is 
different. A correlation analysis is done between the promoter activity in either direction 
and the time it takes to get maximum expression. The correlation coefficients are listed in 
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Table 5.2. It is interesting to see that the Venus expression and the time needed are much 
better correlated than those of mCherry. 
Table 5.2: Correlation coefficients between the maximum fluorescent 
expression and the time needed to reach it.  
 Library A Library B Library C 
Venus 0.733 0.699 0.638 
mCherry 0.570 0.207 0.200 
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Figure 5.7: Promoter activities in library A. 
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Figure 5.8: Promoter activities in library B. 
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Figure 5.9: Promoter activities in library C. 
148 
 
5.2.4 Sequence analysis of the divergent promoters 
All clones are sequenced and the good ones (without big chunks of insertion or deletion) 
were aligned using ClustalW (Figure 5.10, 5.11, and 5.12). However, clones with highly 
resembling sequence, often with one nucleotide different on a certain position, may have 
similar or quite different promoter activities. It‟s likely that not a nucleotide at a certain 
position determines the promoter activity but this nucleotide and its context sequence 
together may form a higher order of structure which facilitates or hinders the 
transcription process.  
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Figure 5.10: Sequence alignment of promoters in library A.  
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Figure 5.11: Sequence alignment of promoters in library B.  
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Figure 5.12: Sequence alignment of promoters in library C.  
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5.3 Materials and methods 
5.3.1 Bacterial strain and plasmids 
E. coli strain Dh5α was used as host for cloning and assaying the activities of the 
synthetic promoters. The divergent promoter probing vector pKW712M was constructed 
based on the plasmid pPROTet.E (Clontech). First, the transcriptional terminator T2 was 
amplified from pSE380 (Invitrogen) using primers KW213F and KW213R and inserted 
into pPROTet.E between XhoI and AatII sites, yielding the plasmid pKW601. Then, two 
reporters were constructed by adding a degradation tag AANDENYAASV [22,34] to the 
C-terminus of yellow fluorescent protein Venus and red fluorescent protein mCherry to 
generate unstable variants Venus-ASV and mCherry-ASV. Two rounds of PCR 
amplifications were conducted to make these variants. First, venus (KW222F and 
KW276R) and mCherry (KW122F and KW277R) are amplified using a reverse primer 
harboring an overhang encoding part of the degradation tag. Second, venus-asv 
(KW222F and KW276R2) and mCherry-asv (KW122 and KW276R2) were amplified 
using the DNA obtained from the first round PCR as the template and a reverse primer 
annealing to the part of degradation tag on the template. The amplified DNA was cloned 
into pPROTet.E between EcoRI and BamHI sites, resulting in pKW596 and pKW597 
respectively. Next, venus-asv (KW222F and KW280R) was cloned into pKW601 
between EcoRI and XhoI sites, yielding the plasmid pKW702 and mCherry-asv 
(KW081F2 and KW281R) was cloned into pKW702 between NotI and XbaI sites, 
resulting in the plasmid pKW706. Lastly, the sequence between EcoRI and NotI on 
pKW706 (the same as that on pPROTet.E) was replaced by a shorter one encoding for 
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cutting sites of enzymes SalI, HindIII, and BamHI, as the original sequence demonstrate 
weak promoter activity and the background expression level of Venus-ASV and 
mCherry-ASV is relatively high. The final series of divergent probing vectors are named 
pKW712X with strong, medium, or weak RBS denoted by S, M, or, W. Table 5.3 and 
5.4 list all the plasmids and primers used in this work. 
 
Figure 5.13: One strategy to synthesize promoters CP25, CP4, and CP7.  
Three synthetic promoters of different strengths from Jensen and Hammer‟s work were 
synthesized and cloned into the promoter probing vector pProbe-gfp [tagless], pKW702, 
and pKW712M to compare their sensitivity. Blunt end ligation using primers with these 
promoter sequences on overhangs and pKW712 as template was utilized to clone 
promoters PCP25, PCP4, and PCP7 to pKW712 between HindIII and EcoRI sites and 
generated plasmids pKW709 (with primers KW390F and KW391R), pKW714 (KW392F 
and KW393R), and pKW726 (KW394F and KW395R). The plasmids pKW710 (with 
primers KW288F, KW289F, KW290R, and KW291R), pKW716 (KW296F, KW297R, 
KW300F, and KW301R), and pKW728 (KW306F, KW307R, KW310F, and KW311R) 
carrying promoters PCP25, PCP4, and PCP7 between HindIII and NotI sites were obtained 
using a different strategy (Figure 5.13). Four primers annealing together generate the 
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promoter with sticky ends which can be ligated with the digested vector pKW712. 
Promoters from pKW709, pKW714, and pKW726 were cut with HindIII and EcoRI sites 
and inserted into pKW702 yielding pKW741, pKW742, and pKW743. These promoters 
were inserted into pProbe-gfp [tagless], resulting in pKW744, pKW745, and pKW746. 
Table 5.3: Plasmids used in this work. 
Plasmids Genotype Reference 
pKW596 pPROTet.E derivative harboring venus-asv, Cm
R
 This work 
pKW597 pPROTet.E derivative harboring mCherry-asv, Cm
R
 This work 
pKW601 pPROTet.E derivative, T2, Cm
R
 This work 
pKW702 pKW601 derivative, venus-asv, Cm
R
 This work 
pKW706 pKW601 derivative, (venus-asv)-(mCherry-asv), Cm
R
 This work 
pKW712 pKW601 derivative, (venus-asv)-(mCherry-asv), Cm
R
 This work 
pKW709 pKW712 derivative, PCP25-(venus-asv), Cm
R
 This work 
pKW710 pKW712 derivative, PCP25-(mCherry-asv), Cm
R
 This work 
pKW714 pKW712 derivative, PCP4-(venus-asv), Cm
R
 This work 
pKW716 pKW712 derivative, PCP4-( mCherry-asv), Cm
R
 This work 
pKW726 pKW712 derivative, PCP7-(venus-asv), Cm
R
 This work 
pKW728 pKW712 derivative, PCP7-( mCherry-asv), Cm
R
 This work 
pKW741 pKW702 derivative, PCP25, Cm
R
  This work 
pKW742 pKW702 derivative, PCP4, Cm
R
 This work 
pKW743 pKW702 derivative, PCP7, Cm
R
 This work 
pKW744 pProbe-gfp [tagless] derivative, PCP25, Km
R
 This work 
pKW745 pProbe-gfp [tagless] derivative, PCP4, Km
R
 This work 
pKW746 pProbe-gfp [tagless] derivative, PCP7, Km
R
 This work 
pKW804 pKW712M derivatives, Promoter A series, Cm
R
 This work 
pKW805 pKW712M derivatives, Promoter C series, Cm
R
 This work 
pKW806 pKW712M derivatives, Promoter B series, Cm
R
 This work 
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pProbe-gfp 
[tagless] p15A ori, promoter-less, gfp [tagless], Km
R
 [22] 
pPROTet.E Cloning vector, ColE1 ori, PLteto-1 promoter, Cm
R
 Clontech 
pSE380 pUC ori, PTrc promoter, lacI
q
, Amp
R
 Invitrogen 
 
Table 5.4: Oligonucleotides used in this work. 
Primers Sequence (5’→3’) 
KW081F2 
ATAGCGGCCGCAACTAAAGATTAACTTTATAAGGAGGAAAA
AC 
KW122F 
TATGAATTCAACTAAAGATTAACGAAATAAGGAGGAAAAAC
ATATG 
KW213F ATTCTCGAGAAAATTGGAGCGGATTTGAACGTTG 
KW213R ATTGACGTCAAAAGGCCATCCGTCAGG 
KW222F 
AAGAATTCAACTAAAGATTAACGAAATAAGGAGGAAAAACA
TATGAGTAAAGGAGAAGA 
KW276R TTCGTCGTTTGCTGCAGGCCTTTTGTATAGTTCATCCATGCC 
KW276R2 
ATAGGATCCTTAAACTGATGCAGCGTAGTTTTCGTCGTTTGCT
GCAGGCCT 
KW277R TTCGTCGTTTGCTGCAGGCCTCTTGTACAGCTCGTCCATGCC 
KW280R ATACTCGAGTTAAACTGATGCAGCGTAGTTTTCG 
KW281R ATATCTAGATTAAACTGATGCAGCGTAGTTTTCG 
KW288F AGCTTCTTTGGCAGTTTATTCTTGACATGTAGTGAGGG 
KW289F GGCTGGTATAATCACATAGTACTGTTGC 
KW290R CCAGCCCCCTCACTACATGTCAAGAATAAACTGCCAAAGA 
KW291R GGCCGCAACAGTACTATGTGATTATA 
KW296F AGCTTGATGTTTTAGTTTATTCTTGACACCGTATCGTGC 
KW297R TCACGCGCACGATACGGTGTCAAGAATAAACTAAAACATCA 
KW300F GCGTGATATAATCGGGATCCTTAAGAGC 
KW301R GGCCGCTCTTAAGGATCCCGATTATA 
Table 5.3 (cont.) 
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KW306F AGCTTTATGCGGTAGTTTATTCTTGACATGACGAGACAG 
KW307R CCACACCTGTCTCGTCATGTCAAGAATAAACTACCGCATAA 
KW310F GTGTGGTATAATGGGTCTAGATTAGGGC 
KW311R GGCCGCCCTAATCTAGACCCATTATA 
KW337F 
GAATTCAACAGTACTNWNNTATTATARCANNNNNNNNTTGA
CATGTCAANNNNNNNNTGRTATAATANNWNAGTACTGTTGC
GGCCGCAT 
KW338F 
ATAGAATTCAACAGTACTTGACAATTATARCANNNNNTGRTA
TAATTGTCAAGTACTGTTGCGGCCGCAT 
KW339F 
ATAGAATTCAACAGTACTNWNNTATTATARCATTGACANNNN
NNNNTGTCAATGRTATAATANNWNAGTACTGTTGCGGCCGCA
T 
KW340F ATGCGGCCGCAACAG 
KW390F 
CACTACATGTCAAGAATAAACTGCCAAAGAAGCTTGGATCCG
CGGCCGC 
KW391R 
AGGGGGCTGGTATAATCACATAGTACTGTTGAATTCAACTAA
AGATTAACG 
KW392F 
GATACGGTGTCAAGAATAAACTAAAACATCAAGCTTGGATCC
GCGGCCGC 
KW393R 
GTGCGCGTGATATAATCGGGATCCTTAAGAGAATTCAACTAA
AGATTAACG 
KW394F 
CTCGTCATGTCAAGAATAAACTACCGCATAAAGCTTGGATCC
GCGGCCGC 
KW395R 
ACAGGTGTGGTATAATGGGTCTAGATTAGGGAATTCAACTAA
AGATTAACG 
KW422F 
TAGAATTCCAACAATACCTACTTAAAAAAGGAGGGGAAAAA
TGAGTAAAGGAGAAGAAC 
KW424F 
AGCGGCCGCCAACAATACCTACTTAAAAAAGGAGGGGAAAA
ATGGTGAGCAAGGGCGAAG 
 
5.3.2 Culture conditions 
Cells were culture in LB, supplemented with chloramphenicol at 25 μg/mL if needed, for 
propagation. For assay, cells were culture in LB for overnight first and then subcultured 
Table 5.4 (cont.) 
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in triplets in M9 minimal media with glucose with a 1:50 dilution to 0.6 mL in deep well 
plates with vigorous shaking for 9 hr at 37°C for end point measurements and to 0.2 mL 
in 96-well plates with medium shaking between every two measurements in the 
microplate reader for kinetic readings. 
5.3.3 Fluorescent protein assay 
For end point measurements, cultures were transferred to 96-well plates and fluorescence 
was measured in using a Tecan Safire2 microplate reader. For Venus expression, the 
excitation wavelength was set at 515 nm and the emission wavelength at 528 nm.  The 
bandwidth was fixed at 5 nm and the gain was set to 100. For mCherry expression, the 
excitation wavelength was set at 587 nm and the emission wavelength at 610 nm.  The 
bandwidth was fixed at 5 nm and the gain was set to 150. Nine readings were taken in 
each well. To correct the variation in cell numbers, the fluorescence intensity was 
normalized by the OD600 of the culture. For kinetic measurements, fluorescence was 
measured in the same way every 20 min.  
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Chapter 6: A Modular Positive Feedback Based Gene 
Amplifier 
6.1 Introduction 
Positive feedback is a common mechanism involved in the regulation of genetic circuits 
[1]. Anytime a gene product has the capacity to enhance its own production, either 
directly or indirectly, the circuit is said to involve positive feedback. A number of 
behaviors can be attributed to positive feedback loops. The defining one is clearly 
amplification. More complex behaviors include bistability and hysteresis. In addition, 
positive feedback is an integral element in many oscillatory, pattern-formation, and 
intracellular polarization processes [2,3].  
In a number of synthetic biology applications, positive feedback has been used to design 
switches, oscillators, and amplifiers. Besckei and coworkers [4], for example, showed in 
yeast that a simple positive feedback loop could transform a graded response to an 
inducer into a binary one. Likewise, Kramer and Fussenegger [5] showed that positive 
feedback could be used to generate hysteresis with respect to an inducer in mammalian 
cells. Maeda and Sano [6] analyzed a synthetic positive feedback loop in E. coli and 
demonstrated that it could give rise to either a graded or hysteretic response depending on 
the specific configuration. In terms of building circuits, Ajo-Franklin and coworkers [7] 
demonstrated that positive feedback could be used to engineer memory into yeast cells. 
Stricker and coworkers [8], on the other hand, built a simple oscillator by coupling 
positive feedback with negative feedback. In work most closely related to the present 
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study, Sayut and coworkers [9,10] demonstrated that a positive feedback loop could make 
the transcriptional activity of the quorum-sensing regulator LuxR more sensitive to 
autoinducer. In these regards, their design is most closely related to how positive 
feedback is typically employed in electronic circuits, namely to amplify the response to a 
signal. 
In this work, we constructed a modular genetic amplifier in Escherichia coli based on a 
constitutively active, autoinducer-independent variant of the quorum-sensing regulator 
LuxR from Vibrio fischeri [11]. Our goal was to develop a simple network component 
that could be coupled to any cell-based sensing system where the output involves the 
transcription of some gene. In these regards, we sought to engineer an “off the shelf” 
device that could be readily implemented in any gene circuit. To test the ability of this 
device to amplify a transcriptional output, we coupled our device to a one-component 
tetracycline sensor and a two-component aspartate sensor. In both cases, we found that 
our amplifier was able to increase the sensitivity to the input signal and intensify the 
output signal.  
6.2 Results 
6.2.1 Design of positive-feedback amplifier 
In order to construct a positive feedback circuit, we required a transcriptional activator 
that did not interfere with native gene regulation in E. coli. In addition, we required that 
the activator be constitutively active and not dependent on the addition of an exogenous 
inducer. Given these constraints, we chose the LuxR protein from Vibrio fischeri. [11]. 
This protein, normally involved in quorum sensing and bioluminescence, activates the 
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transcription of the luxIADCBE operon in response to acyl homoserine lactone (AHL) 
which can be synthesized by the protein LuxI. AHL binding stabilizes the LuxR dimer 
and, as a result, increases its ability to activate transcription [12,13,14] (Figure 6.1).  
 
Figure 6.1: Mechanism underlying the lux operon. 
While wild-type LuxR does not appear to interfere with native E. coli regulation, it still 
requires an exogenous inducer. However, a number of approaches exist for making 
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constitutively active derivatives of LuxR and thus satisfying our design constraints. For 
example, an Ala221Val point mutation was previously found to constitutively activate 
LuxR [15]. The alanine at position 221 enables the N-terminal signaling domain to inhibit 
the activity of the C-terminal, DNA-binding domain. Presumably, mutating this residue 
to a valine prevents the N-terminal domain from interfering with DNA binding. 
Consistent with this model, deleting the N-terminal domain of LuxR was also found to 
yield a constitutively active variant [16,17]. 
 
Figure 6.2: Comparison of LuxR and its mutants.  
Based on these previous studies, we engineered three constitutively active variants of 
LuxR to test their suitability in designing an amplifier (Figure 6.2). The first, denoted by 
LuxR*, harbors the Ala221Val point mutation. The other two, denoted by LuxRΔ2-156 and 
LuxRΔ2-162 respectively, involved different N-terminal deletions, where the subscript 
denotes the deleted fragment. To test the relative effectiveness of these three different 
constitutive LuxR variants, we determined how strongly they could activate expression 
from the PluxI promoter, using the green fluorescent protein (GFP) as our transcriptional 
readout. The results from these experiments are shown in Figure 6.3. All of the LuxR 
variants, including the wild-type control, were able to induce expression from the PluxI 
promoter. Of the three, only LuxRΔ2-162 was capable in our hands of enhancing 
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transcription relative to the wild-type control. Based on these results, we chose to use the 
LuxRΔ2-162 variant to design the amplifier.   
 
Figure 6.3: Comparison of constitutive LuxR variants.  
In these experiments, LuxR was expressed from a tetracycline-inducible promoter, PLtetO-1, 
in strain GN101, which harbors a chromosomal copy of tetR. Activity was determined by 
the ability of these different variants to induce expression from the PluxI promoter, using 
GFP as the readout, in the absence of any autoinducer. Dark bars denote the uninduced 
case and light bars the induced case (200 ng/mL aTc). Error bars denote 95% confidence 
intervals. 
To construct the amplifier, we cloned GFP and LuxRΔ2-162 in a bicistronic configuration 
behind the PluxI promoter on high-copy number plasmid (ColE1 origin of replication). In 
this arrangement, LuxRΔ2-162 functions in a positive feedback loop as it can bind to the 
PluxI promoter and activate its own transcription (Figure 6.4). The reason we cloned 
LuxRΔ2-162 downstream of the GFP reporter is to control for polar effects when we 
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compared results involving positive feedback to those lacking it. To induce this circuit, 
we again used LuxRΔ2-162, this time as the input signal. In such a design, the output of the 
sensor is LuxRΔ2-162, which in turn feeds back into the amplifier. In these regards, 
LuxRΔ2-162 is used both as the input and positive feedback signal. For the output, we used 
GFP as it provides a facile measure of transcriptional activity. This choice is in no way 
limiting, and any gene can in practice be used as the output. 
 
Figure 6.4: Schematic of positive-feedback amplifier. 
The basic design for the amplifier consists of GFP and LuxRΔ2-162 arranged in a 
bicistronic configuration under the control of the PluxI promoter. LuxRΔ2-162 functions in a 
positive feedback loop as it can bind to the PluxI promoter and activate its own 
transcription. In our design, LuxRΔ2-162 is also used as the input signal to for the amplifier. 
LuxRΔ2-162, therefore, is used both as the input and positive feedback signal. GFP 
provides a measure of transcriptional activity.  
6.2.2 Validation of amplifier using a tetracycline sensor 
We first tested the amplifier by coupling it to a one-component tetracycline sensor 
(Figure 6.5). In this design, we cloned LuxRΔ2-162 behind the TetR-regulated PLtetO-1 
promoter on a compatible, medium copy-number plasmid (p15A origin of replication) 
[18]. In the absence of the tetracycline analogue, anhydrotetracycline (aTc), dimeric TetR 
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binds to the O2 operator sites within the PLtetO-1 promoter and represses transcription. 
However, when TetR is bound with aTc, it no longer binds and represses the PLtetO-1 
promoter, enabling dose-dependent control of gene expression. Thus, the aTc-inducible 
promoter functions as a one-component tetracycline sensor with LuxRΔ2-162 as the output. 
 
Figure 6.5: Schematic of tetracycline sensor coupled to the positive-feedback 
amplifier. 
The one-component tetracycline sensor consists of a plasmid where LuxRΔ2-162 has been 
cloned behind the TetR-regulated PLtetO-1 promoter. In the absence of the inducer 
anhydrotetracycline (aTc), dimeric TetR binds to the O2 operator sites within the PLtetO-1 
promoter and represses transcription. However, when bound with aTc, TetR is no longer 
able to bind to the O2 operators sites within the promoter, thus enabling dose-dependent 
control of LuxRΔ2-162. This sensor was been coupled with the positive feedback amplifier, 
encoded on a separate plasmid, by transforming cells (GN100) constitutively expressing a 
chromosomal copy of the tetR gene with the two plasmids respectively harboring the 
sensor and amplifier. 
To couple this sensor with the amplifier, we transformed cells (GN100) constitutively 
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expressing a chromosomal copy of the tetR gene with the two plasmids respectively 
harboring the sensor and amplifier (see Materials and Methods for details). A schematic 
of the integrated design is given in Figure 6.5. When we tested this design, we found that 
the amplifier increased both the sensitivity and dynamic range of the integrated circuit 
relative to an otherwise identical circuit lacking positive feedback (Figure 6.6). In 
particular, we found that positive feedback increased the sensitivity to aTc by roughly 
two orders of magnitude. In other words, we observed equivalent levels of expression in 
the circuit involving positive feedback at aTc concentrations roughly one hundred times 
less than those observed with the circuit lacking positive feedback. Moreover, we found 
that positive feedback increased the dynamic range by roughly 50%. By range, we mean 
the ratio of expression under saturating inducing (100 ng/ml aTc) and non-inducing (0 
ng/ml aTc) conditions.  
 
Figure 6.6: Comparison of tetracycline sensor with positive feedback (solid 
circles) and without (solid square).  
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The design lacking positive feedback is otherwise identical to one with positive feedback 
except that only GFP is expressed from the PluxI promoter. In these experiments, cells 
were grown overnight at the indicated concentration of aTc to an OD600 prior to 
measurements. The fluorescence values were normalized with the OD600 absorbance to 
account for cell density. Error bars denote 95% confidence intervals for the measurement 
average. 
In addition to these endpoint measurements, we also performed kinetic experiments 
where we measured the response over a twelve-hour interval to varying concentrations of 
aTc (Figure 6.7). Consistent with our end-point measurements, we found that the design 
involving positive feedback was more sensitive to aTc and had a wider dynamic range of 
expression levels. Collectively, these results demonstrate that our genetic amplifier is 
capable of both increasing the sensitivity and dynamic range of this one-component 
tetracycline sensor. 
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Figure 6.7: Kinetic analysis of tetracycline sensor with positive feedback (A) 
and without (B). 
In these experiments, cells were grown for 12 hours at varying levels of aTc induction 
with measurements taken every hour. The fluorescence values were normalized with the 
OD600 absorbance to account for cell density. The scale for both sets of experiments is the 
same.  Error bars denote 95% confidence intervals for the measurement average.  
We last tested whether the amplifier would endow the cell with memory. While not a 
design goal, multiple studies have shown that positive feedback can lead to bistability and 
hysteresis [1,5,19]. Therefore, we speculated that cells harboring the amplifier might be 
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able to “remember” previous exposures to aTc. However, when we transferred cells from 
media containing aTc to media lacking it, we no longer observed any GFP expression 
relative to the background after we grew the cells up (data not shown). These results 
indicate the positive feedback loop involving LuxRΔ2-162 is able to amplify the response 
to an inducer but is incapable of sustaining the response in the absence of inducer.  
Based on what we know about the properties of LuxR, specifically the role of AHL in 
stabilizing LuxR, the reason the circuit does not sustain activation is likely due to the 
protein dimer being degraded too quickly. In other words, we suspect that LuxRΔ2-162 
dimer is being degraded at a rate greater than it is being produced by positive feedback 
alone (though we did not directly make this measurement). More specifically, positive 
feedback alone is unable to sustain the expression of LuxRΔ2-162in the absence of some 
exogenous source, in our case the one-component sensor. That said, the positive feedback 
is still strong enough to amplify the response when an external input signal is present.  
6.2.3 Validation of amplifier using an aspartate sensor 
We next tested the amplifier by coupling it to a two-component aspartate sensor (Figure 
6.8). To do this, we used the hybrid Tar-EnvZ (Taz) sensor kinase [20]. This chimeric, 
transmembrane sensor kinase controls the levels of phosphorylated OmpR, which in turn 
activates the expression from the PompC promoter. When the Taz sensor kinase is bound 
with aspartate, it increases the levels of OmpR-P, leading to increased expression from 
the PompC promoter. In addition to amino acids, EnvZ chimeras have been constructed to 
sense other inputs such as sugars and light [21,22]. 
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Figure 6.8: Schematic of aspartate sensor coupled to the positive-feedback 
amplifier. 
The two-component sensor consists of the Taz sensor kinase and the OmpR response 
regulator. Taz controls the level of phosphorylated OmpR (OmpR-P), which in turn 
activates the expression from the PompC promoter. When the Taz sensor kinase is bound 
with aspartate, it increases the levels of OmpR-P, leading to increased expression from 
the PompC promoter. In our design, the Taz sensor kinase has been cloned behind the 
constitutive PLtetO-1 promoter on one plasmid (the cells used in these experiments do not 
possess TetR).  On a second plasmid, LuxRΔ2-162 has been cloned behind the PompC 
promoter, resulting in the expression of LuxRΔ2-162 being aspartate dependent. The third 
plasmid harbors the positive feedback amplifier. The sensor was coupled to the amplifier 
by transforming the three plasmids into a ΔenvZ null mutant (GN101). 
In order to couple the two-component aspartate sensor with our genetic amplifier, we 
cloned LuxRΔ2-162 behind PompCpromoter on a compatible, medium copy-number plasmid 
(p15A origin of replication). To introduce the Taz sensor kinase into E. coli, we cloned 
this gene behind the constitutive PLtetO-1promoter on a compatible, low copy-number 
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plasmid (pSC101 origin of replication). Note, these experiments were performed in cells 
lacking a chromosomal copy of the tetR gene, so the PLtetO-1 promoter in this background 
is constitutive. To construct the integrated circuit in E. coli, we transformed a ΔenvZ null 
mutant (GN101) with these three plasmids. 
Similar to what we observed with the one-component tetracycline receptor, we found that 
the amplifier increased both the range and sensitivity when coupled to the two-
component aspartate sensor as compared to an otherwise identical circuit lacking positive 
feedback (Figure 6.9). Unlike the case with the one-component sensor, we observed only 
a minor increase in sensitivity. However, we observed a significant amplification of the 
response. In particular, the amplifier increased the dynamic range by roughly an order of 
magnitude whereas the sensitivity increased by approximately a factor of two. These 
results demonstrate that the amplifier is modular as it can readily be applied to different 
sensor systems. They also demonstrate that the performance of the amplifier is context 
dependent. In particular, we observed mostly an increase in the range when the amplifier 
was coupled to the Taz sensor kinase and, conversely, mostly an increase in sensitivity 
when it was coupled to the one-component tetracycline sensor. 
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Figure 6.9: Comparison of sensor output in the presence (solid circles) and 
absence (solid squares) of the positive feedback amplifier.  
The design lacking positive feedback is otherwise identical to one with positive feedback 
except that only GFP is expressed from the PluxI promoter. In these experiments, cells 
were grown overnight at the indicated concentration of aspartate prior to measurements. 
The fluorescence values were normalized with the OD600 absorbance to account for cell 
density. Inset figure shows the magnification of the response for the design lacking 
positive feedback. Error bars denote 95% confidence intervals for measured averages. 
We observed only weak activation, roughly two-fold, in response to aspartate in the 
absence of positive feedback. This level of activation is less than what has been 
previously observed in other studies using Taz, where the degree of activation is greater 
than tenfold [23,24]. However, unlike of our design, these studies measured the 
expression from the PompC promoter.  In the present work, we measured the expression 
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from a downstream promoter, PluxI. Thus, there is an additional stage between the sensor 
and reporter in our design. Likely, expression of LuxRΔ2-162 from the PompC promoter is 
not sufficiently strong to activate the PluxI promoter without further amplification. 
However, when we add amplification by including positive feedback, we then obtain 
robust expression. 
6.3 Discussions 
In this work, we developed a simple modular genetic amplifier based on a constitutively 
active variant of LuxR. We tested this amplifier by coupling it to a one-component 
tetracycline sensor and a two-component aspartate sensor. In both instances, the amplifier 
was able to increase the dynamic range and sensitivity of the integrated circuit. Based on 
these results, this amplifier most likely can be coupled to any cell-based sensor where the 
output involves the transcription of a gene. In these regards, we have successfully 
constructed a reusable component.  
In addition to sensing applications, the amplifier can also be used to create devices of 
greater complexity in function. One intriguing application concerns impedance matching. 
Impedance mismatch occurs when the output range of one sub-circuit does not match the 
input range of another sub-circuit to which it is connected. To effectively link these two 
sub-circuits, the respective output and input ranges should match one another. As positive 
feedback can significantly alter the response of a sub-circuit, it can be used as an 
„impedance matching‟ device by couple two different sub-circuit circuits together that 
have disparate requirements for signal levels to operate correctly.  
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A primary goal of synthetic biology is to design modular components with defined 
behavior that can be reused in diverse applications [25,26,27,28]. The ideal component 
should have predicable behavior regardless of the context in which it is applied. This is a 
significant challenge. Even in our experiments, while we rightly hypothesized that we 
would see amplification due to the positive feedback, we see a different response when 
we coupled the amplifier to the two different sensors. For instance, the tetracycline sensor 
showed a major increase in sensitivity but only moderate increase in the dynamic 
response. The aspartate sensor, however, showed a major increase in the dynamic 
response but only a moderate increase in sensitivity. Moreover, the amplifier increased 
background expression in the case of the aspartate sensor but not in the case of the 
tetracycline sensor. The origins of these differences are unknown, but may arise to 
variations, for example, in plasmid copy number, promoter strengths, and the metabolic 
burden imposed by each circuit. While further engineering can be used to control for 
these individual factors, their effects are often non-trivial to isolate and quantify. 
6.4 Materials and methods 
6.4.1 Media, growth conditions, and bacterial strains 
All cultures experiments were performed in either Luria-Bertani (LB) or M9 minimal 
media supplement with 0.4% glucose, 1 μg/mL thiamine, and 1 μg/mL biotin. All 
experiments were performed at 37˚C unless noted otherwise. Antibiotics were used at the 
following concentrations: ampicillin at 100 µg/mL, chloramphenicol at 20 µg/mL, and 
kanamycin at 40 µg/mL.  
All cloning steps were performed in E. coli strain DH5α. Subsequent experiments 
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involving anhydrotetracycline induction were conducted in E. coli strain GN100 (F
-
ilvGrfb-50rph-1ΔenvZ::FRT attBλ::[PN25-tetRlacI
q
spcR]) and those involving aspartate 
induction were performed in GN101 (F
-
ilvGrfb-50rph-1ΔenvZ::FRT). Strain GN100 was 
constructed first by P1vir transduction of the ΔenvZ::kan insert from JW3367-3 (The E. 
coli Genetic Stock Center, CGSC# 10509) into MG1655. The antibiotic cassette from the 
FRT-Kan-FRT insert was then removed by transformation of pCP20 into the strain and 
selection on ampicillin at 30˚C [29]. Loss of the helper plasmid pCP20 was obtained by 
growth at 42˚C under non-selective conditions on LB agar. Lastly, the chromosomally 
integrated TetR/LacI expression cassette from DH5αZ1 [18] was moved into this strain 
by P1vir transduction, yielding GN100. Similarly, strain GN101 was constructed in an 
identical manner except that it does not harbor the TetR/LacI expression cassette from 
DH5αZ1. 
6.4.2 Plasmids construction 
All the plasmids used in this study are described in Table 6.1. All the primers used for 
cloning are listed in Table 6.2. 
Table 6.1: Plasmids used in this work. 
Plasmids Genotype Reference 
pGN3 p15A ori, PLtetO-1-luxR*, Km
R
 This work 
pGN11 p15A ori, PLtetO-1-luxR2-156, Km
R
 This work 
pGN12 p15A ori, PLtetO-1-luxR2-162, Km
R
 This work 
pGN23 ColE1 ori, PluxI, Cm
R
 This work 
pGN62 p15A ori, POmpC-luxR2-162, Km
R
 This work 
pGN68 ColE1 ori, PluxI -GFP [tagless]-luxR2-162, Cm
R
 This work 
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pGN69 ColE1 ori, PluxI-GFP[tagless], Cm
R
 This work 
pGN76 ColE1 ori, PLtetO-1-taz, Amp
R
 This work 
pGN77 pSC101 ori, PLtetO-1-taz, Amp
R
 This work 
pluxGFPuv ColE1 ori, PluxI-gfpuv, Cm
R
 [30] 
pLuxRI2 ColE1 ori, Plac/ara-1-luxR-luxI, Cm
R
 [30] 
pPROTet.E Cloning vector, ColE1 ori, PLteto-1 promoter, Cm
R
 Clontech 
pPROTet.E-
Amp ColE1 ori, PLteto-1 promoter, Amp
R
 This work 
pPROTet.E-
Kan-p15A p15A ori, PLteto-1 promoter, Amp
R
 This work 
pTJ003 p15A ori, Plpp-taz, Amp
R
 [31] 
pZA34-luc p15A ori, Plac/ara-1-luc, Cm
R
 [18] 
pZE12 ColE1 ori, PLlacO-1-luc, Amp
R
 [18] 
pZE21 ColE1 ori, PLtetO-1, Km
R
 [18] 
pZS24 pSC101 ori, Plac/ara-1, Km
R
 [18] 
 
Table 6.2: Oligonucleotides used in this work. 
Primers Sequence (5’→3’) 
GN03F GGGCTCGAGGTTCCCTTGCATTTACATTTT 
GN05R GGGGAATTCTAACTTTCATGTTATTAACCC 
GN06F2 GGGGTCGACATGCCTTCTCTAGTTGATAA 
GN09F 
GGGGGATCCAACTAAAGATTAACTTTATAAGGAGGAAAAAC
AT 
GN09F2 
AACTAAAGATTAACTTTATAAGGAGGAAAAACATATGCCTTC
TCTAGTTGATAAT 
GN10F 
GGGGAATTCATACGTATTTAAATCAGGAGTGGAAATGAGTAA
AGGAGAAGAACTT 
GN10R GGGGGATCCTTATTATTTGTATAGTTCATCCA 
GN12R GGGGTCGACTTACCCTTCTTTTGTCGTGCCCT 
Table 6.1 (cont.) 
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GN13F 
GGGGAATTCTTAAAGAGGAGAAAGGTACCCATGATTAACCGT
ATCC 
KW078F1 
AACTTTATAAGGAGGAAAAACATATGAAAAACATAAATGCC
GAC 
KW078F2 TATGAATTCAACTAAAGATTAACTTTATAAGGAGGAAAAACA 
KW078R ACTGTCGACTTAATTTTTAAAGTATGGGC 
KW079F ATAGGTCTCTGTGCAAATGAAACTCAATACAAC 
KW079R ATAGGTCTCTGCACATTGGTTAAATGGAAAGTGA 
KW112F 
AACTTTATAAGGAGGAAAAACATATGAACATACCATTAATTG
TTCC 
KW113F 
CTTTATAAGGAGGAAAAACATATGCCTTCTCTAGTTGATAATT
ATC 
KW134F CAGATATCGACGTCAGTCC 
KW134R2 ATAGAATTCTGCGTTTATTCGACTATAAC 
KW171R AATAGCGGCCGCTTATTAATTTTTAAAGTATGGGC 
 
The plasmid pPROTet.E-Kan-p15A was made by swapping the ColE1 origin of 
pPROTet.E with the p15A origin from pZA34-luc using the restriction sites XbaI and 
SacI and by swapping the chloramphenicol resistance gene with the kanamycin resistance 
gene from pZE21 using the restriction sites XhoI and SacI. The plasmid pPROTet.E-Amp 
was made by replacing the chloramphenicol resistance gene in pPROTet.E with the 
ampicillin resistance gene from pZE12 using the restriction sites XhoI and SacI. 
The luxI-GFP transcriptional fusion was made first by PCR amplification of the luxI 
promoter using the plasmid pluxGFPuv [30] as the template with the primers KW134F 
and KW134R2. The resulting fragment was then cloned into the plasmid pPROTet.E 
using the restriction sites EcoRI and AatII, yielding the plasmid pGN23. The green 
fluorescent protein (GFP) was PCR amplified from pPROBE-gfp[tagless] [32] using 
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primers GN10F and GN10R. The resulting fragment was then cloned into the EcoRI and 
BamHI restriction sites of the pGN23, yielding the plasmid pGN69.  
The LuxR* (LuxR [A221V]) expression plasmids were constructed using two rounds of 
PCR. In the first round, the luxR gene was amplified with primers KW78F1 and 
KW078R using pLuxRI [30] as the template. The resulting product was then used as a 
template for a second round of PCR this time using primers KW078F2 and KW078R. It 
was then digested with EcoRI and SalI and sub-cloned into the EcoRI and SalI cut-sites 
of pPROTetE-Kan-p15A. Enzymatic inverse PCR was used to introduce the Ala221Val 
(GCG->GTG) point mutation in the luxR gene with primers KW079F and KW079R. The 
resulting PCR product was then digested with BsaI and ligated to obtain pGN3.  
The luxRΔ2-156 expression plasmid was also constructed using two rounds of PCR. The 
luxR gene was first amplified with primers KW112F and KW078R using pLuxRI2 as the 
template. The resulting PCR product was then amplified using primers KW078F2 and 
KW078R. It was then cloned into the EcoRI and SalI cut-sites of pPROTetE-Kan-p15A, 
yielding pGN11. Likewise, the luxRΔ2-162 expression plasmid was made by amplifying 
the luxR gene with primers KW113F and KW078R using pLuxRI2 as the template. The 
resulting product was amplified again as before using primers KW078F2 and KW078R. 
The PCR product was then digested with EcoRI and SalI and sub-cloned into the EcoRI 
and SalI cut-sites of pPROTetE-Kan-p15A, yielding pGN12. 
The positive-feedback module was constructed using two rounds of PCR. In the first 
round, the primers GN09F2 and KW171R were used to amplify the luxRΔ2-162 domain 
[33] using pLuxRI2 [30] as the template. The resulting PCR product was then used as 
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template for a second round of PCR this time using primers GN09F and KW171R. The 
resulting fragment was then digested with BamHI and NotI and sub-cloned into pGN69, 
yielding pGN68.  
The aspartate positive feedback module was constructed first by amplifying the PompC 
promoter (genomic region 2310762-2310962) using primers GN03F and GN05R. The 
PCR product was then digested with XhoI and EcoRI and sub-cloned into the respective 
sites of pPROTetE-Kan-p15A, thus replacing the native PLtetO-1promoter with the PompC 
promoter. The primers GN06F2 and KW171R were used to amplify luxRΔ2-162 using 
pGN68 as the template. The resulting PCR product was digested with SalI and NotI and 
then sub-cloned into the respective sites of pPROTetE-Kan-p15A, yielding pGN62. 
The aspartate sensor module was constructed first amplifying the taz gene from pTJ003 
using the primers GN13F and GN12R. The PCR product was then digested with EcoRI 
and SacI and cloned into the unique respective restriction sites, yielding pGN76. The 
ColE1 origin in pGN76 was then replaced with the pSC101 origin from the pZS24 
plasmid using the restriction sites AvrII and SacI, yielding pGN77.  
6.4.3 Fluorescence assays 
To measure fluorescent protein expression, cultures were first grown overnight and then 
subcultured to an OD600 of 0.05 in fresh media. The cultures were first allowed to grow to 
an OD600 of 0.20, at which point the inducer was added. The cultures were then grown 
overnight to prior to taking the measurements. 100 µL of the culture was then transferred 
into a 96 well microplate, and the relative fluorescence and optical density at 600 nm 
(OD600) were measured using a Tecan Safire2 microplate reader. The fluorescence 
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readings, given as relative fluorescence units (RFU), were normalized with the OD600 
absorbance to account for cell density. All experiments were performed in triplicate with 
95% confidence intervals reported. 
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